| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.793 | 0.004 | 0.793 | Anticonvulsant | 0.312 0.037 DBMET00333 0.576 0.008 DBMET00103 0.498 0.012 DBMET00104 0.143 0.138 DBMET00105 0.469 0.014 DBMET00106 0.384 0.024 DBMET01676 0.39 0.023 DBMET00252 0.312 0.037 DBMET01212 | ||
| 0.756 | 0.004 | 0.848 | Dopamine antagonist | 0.234 0.016 DBMET00333 0.163 0.024 DBMET00103 0.597 0.004 DBMET00104 0.848 0.003 DBMET00106 0.115 0.033 DBMET01211 0.234 0.016 DBMET01212 | DBMET00106 | |
| 0.743 | 0.004 | 0.824 | Dopamine D2 antagonist | 0.202 0.017 DBMET00333 0.146 0.023 DBMET00103 0.585 0.004 DBMET00104 0.824 0.003 DBMET00106 0.094 0.034 DBMET01211 0.202 0.017 DBMET01212 | DBMET00106 | |
| 0.721 | 0.003 | 0.892 | Dopamine D4 antagonist | 0.257 0.009 DBMET00333 0.129 0.02 DBMET00103 0.507 0.004 DBMET00104 0.892 0.003 DBMET00106 0.126 0.02 DBMET01211 0.257 0.009 DBMET01212 | DBMET00106 | |
| 0.675 | 0.003 | 0.675 | Dopamine D1 antagonist | 0.161 0.014 DBMET00333 0.303 0.005 DBMET00103 0.561 0.003 DBMET00104 0.606 0.003 DBMET00106 0.059 0.052 DBMET01676 0.123 0.019 DBMET01211 0.161 0.014 DBMET01212 | ||
| 0.677 | 0.016 | 0.769 | Analgesic | 0.232 0.2 DBMET00333 0.769 0.008 DBMET00103 0.683 0.015 DBMET00104 0.714 0.012 DBMET00105 0.442 0.068 DBMET00106 0.24 0.192 DBMET01211 0.232 0.2 DBMET01212 | DBMET00103 | |
| 0.61 | 0.004 | 0.807 | 5 Hydroxytryptamine 2B antagonist | 0.495 0.005 DBMET00333 0.176 0.032 DBMET00103 0.407 0.008 DBMET00104 0.807 0.003 DBMET00106 0.095 0.09 DBMET01676 0.252 0.019 DBMET01211 0.495 0.005 DBMET01212 | DBMET00106 | |
| 0.591 | 0.005 | 0.814 | 5 Hydroxytryptamine 2 antagonist | 0.479 0.007 DBMET00333 0.162 0.04 DBMET00103 0.502 0.006 DBMET00104 0.814 0.003 DBMET00106 0.322 0.015 DBMET01211 0.479 0.007 DBMET01212 | DBMET00106 | |
| 0.549 | 0.004 | 0.791 | 5 Hydroxytryptamine 2C antagonist | 0.435 0.005 DBMET00333 0.175 0.021 DBMET00103 0.314 0.008 DBMET00104 0.791 0.003 DBMET00106 0.193 0.018 DBMET01211 0.435 0.005 DBMET01212 | DBMET00106 | |
| 0.528 | 0.004 | 0.724 | 5 Hydroxytryptamine 2A antagonist | 0.391 0.007 DBMET00333 0.128 0.035 DBMET00103 0.45 0.005 DBMET00104 0.724 0.003 DBMET00106 0.244 0.015 DBMET01211 0.391 0.007 DBMET01212 | DBMET00106 | |
| 0.495 | 0.003 | 0.659 | Dopamine uptake inhibitor | 0.195 0.006 DBMET00333 0.293 0.004 DBMET00103 0.659 0.003 DBMET00104 0.391 0.004 DBMET00106 0.054 0.044 DBMET01676 0.051 0.048 DBMET00252 0.269 0.005 DBMET01211 0.195 0.006 DBMET01212 | DBMET00104 | |
| 0.493 | 0.004 | 0.563 | Histamine H1 receptor antagonist | 0.273 0.008 DBMET00333 0.122 0.032 DBMET00103 0.464 0.004 DBMET00104 0.085 0.053 DBMET00105 0.563 0.004 DBMET00106 0.12 0.032 DBMET01676 0.096 0.044 DBMET00252 0.238 0.01 DBMET01211 0.273 0.008 DBMET01212 | DBMET00106 | |
| 0.491 | 0.004 | 0.601 | NMDA receptor antagonist | 0.107 0.043 DBMET00333 0.534 0.004 DBMET00103 0.601 0.004 DBMET00104 0.27 0.008 DBMET00106 0.132 0.03 DBMET01676 0.142 0.027 DBMET00252 0.175 0.018 DBMET01211 0.107 0.043 DBMET01212 | DBMET00104 | |
| 0.489 | 0.004 | 0.49 | Nav1.1 sodium channel blocker | 0.149 0.033 DBMET00333 0.49 0.004 DBMET00103 0.436 0.004 DBMET00104 0.154 0.031 DBMET00105 0.23 0.014 DBMET00106 0.146 0.035 DBMET01676 0.129 0.042 DBMET00252 0.091 0.079 DBMET01211 0.149 0.033 DBMET01212 | DBMET00103 | |
| 0.499 | 0.015 | 0.599 | HERG channel blocker | 0.166 0.114 DBMET00333 0.592 0.009 DBMET00103 0.599 0.008 DBMET00104 0.278 0.055 DBMET00106 0.239 0.071 DBMET01211 0.166 0.114 DBMET01212 | DBMET00104 | |
| 0.492 | 0.015 | 0.594 | Potassium channel (Voltage-sensitive) blocker | 0.19 0.103 DBMET00333 0.571 0.009 DBMET00103 0.594 0.008 DBMET00104 0.275 0.057 DBMET00106 0.279 0.056 DBMET01211 0.19 0.103 DBMET01212 | DBMET00104 | |
| 0.466 | 0.004 | 0.605 | CC chemokine receptor antagonist | 0.605 0.004 DBMET00103 0.484 0.004 DBMET00104 0.08 0.051 DBMET00106 | DBMET00103 | |
| 0.464 | 0.009 | 0.778 | 5 Hydroxytryptamine antagonist | 0.328 0.016 DBMET00333 0.151 0.049 DBMET00103 0.394 0.012 DBMET00104 0.778 0.004 DBMET00106 0.21 0.032 DBMET01211 0.328 0.016 DBMET01212 | DBMET00106 | |
| 0.454 | 0.002 | 0.454 | CC chemokine 1 receptor antagonist | 0.03 0.012 DBMET00333 0.173 0.004 DBMET00103 0.405 0.002 DBMET00104 0.034 0.011 DBMET00106 0.028 0.014 DBMET01211 0.03 0.012 DBMET01212 | ||
| 0.453 | 0.005 | 0.453 | Nav1.2 sodium channel blocker | 0.205 0.033 DBMET00333 0.258 0.02 DBMET00103 0.369 0.009 DBMET00104 0.322 0.013 DBMET00106 0.121 0.082 DBMET01676 0.146 0.059 DBMET01211 0.205 0.033 DBMET01212 | ||
| 0.449 | 0.004 | 0.512 | Dopamine D3 antagonist | 0.14 0.017 DBMET00333 0.114 0.021 DBMET00103 0.332 0.005 DBMET00104 0.512 0.004 DBMET00106 0.072 0.036 DBMET01211 0.14 0.017 DBMET01212 | DBMET00106 | |
| 0.446 | 0.005 | 0.604 | Chemokine receptor antagonist | 0.604 0.004 DBMET00103 0.445 0.005 DBMET00104 0.087 0.078 DBMET00106 | DBMET00103 | |
| 0.447 | 0.016 | 0.487 | Potassium channel blocker | 0.284 0.052 DBMET00333 0.369 0.028 DBMET00103 0.487 0.012 DBMET00104 0.311 0.043 DBMET00106 0.287 0.051 DBMET01211 0.284 0.052 DBMET01212 | DBMET00104 | |
| 0.46 | 0.039 | 0.626 | Cholesterol antagonist | 0.584 0.021 DBMET00103 0.568 0.023 DBMET00104 0.626 0.015 DBMET00105 0.587 0.02 DBMET01676 0.557 0.024 DBMET00252 0.272 0.11 DBMET01211 | DBMET00105 | |
| 0.423 | 0.005 | 0.52 | Alpha 1b adrenoreceptor antagonist | 0.143 0.023 DBMET00333 0.115 0.031 DBMET00103 0.52 0.004 DBMET00104 0.476 0.004 DBMET00106 0.18 0.017 DBMET01211 0.143 0.023 DBMET01212 | DBMET00104 | |
| 0.418 | 0.004 | 0.418 | Nav1.3 sodium channel blocker | 0.279 0.011 DBMET00333 0.214 0.02 DBMET00103 0.376 0.005 DBMET00104 0.311 0.008 DBMET00106 0.124 0.07 DBMET01676 0.111 0.084 DBMET00252 0.224 0.018 DBMET01211 0.279 0.011 DBMET01212 | ||
| 0.403 | 0.005 | 0.576 | 5 Hydroxytryptamine 1A antagonist | 0.153 0.02 DBMET00333 0.104 0.031 DBMET00103 0.468 0.005 DBMET00104 0.576 0.004 DBMET00106 0.155 0.019 DBMET01211 0.153 0.02 DBMET01212 | DBMET00106 | |
| 0.389 | 0.005 | 0.613 | 5 Hydroxytryptamine 7 antagonist | 0.223 0.01 DBMET00333 0.202 0.012 DBMET00103 0.213 0.011 DBMET00104 0.613 0.004 DBMET00106 0.06 0.045 DBMET01211 0.223 0.01 DBMET01212 | DBMET00106 | |
| 0.418 | 0.037 | 0.608 | Spasmolytic | 0.189 0.129 DBMET00333 0.304 0.069 DBMET00103 0.58 0.015 DBMET00104 0.608 0.012 DBMET00105 0.371 0.047 DBMET00106 0.341 0.055 DBMET01676 0.318 0.063 DBMET00252 0.33 0.059 DBMET01211 0.189 0.129 DBMET01212 | DBMET00105 | |
| 0.383 | 0.004 | 0.383 | Nav1.6 sodium channel blocker | 0.22 0.014 DBMET00333 0.202 0.019 DBMET00103 0.281 0.007 DBMET00104 0.266 0.008 DBMET00106 0.169 0.036 DBMET01676 0.161 0.043 DBMET00252 0.159 0.045 DBMET01211 0.22 0.014 DBMET01212 | ||
| 0.38 | 0.003 | 0.38 | 5 Hydroxytryptamine 5A antagonist | 0.132 0.01 DBMET00333 0.142 0.008 DBMET00103 0.219 0.005 DBMET00104 0.232 0.004 DBMET00106 0.07 0.031 DBMET01211 0.132 0.01 DBMET01212 | ||
| 0.383 | 0.007 | 0.468 | Antipruritic | 0.217 0.038 DBMET00333 0.346 0.009 DBMET00103 0.468 0.005 DBMET00104 0.153 0.091 DBMET00105 0.206 0.045 DBMET00106 0.191 0.055 DBMET01676 0.195 0.053 DBMET00252 0.276 0.018 DBMET01211 0.217 0.038 DBMET01212 | DBMET00104 | |
| 0.369 | 0.008 | 0.533 | Alpha 1 adrenoreceptor antagonist | 0.15 0.029 DBMET00333 0.104 0.042 DBMET00103 0.492 0.005 DBMET00104 0.533 0.004 DBMET00106 0.193 0.022 DBMET01211 0.15 0.029 DBMET01212 | DBMET00106 | |
| 0.368 | 0.007 | 0.577 | 5 Hydroxytryptamine 1 antagonist | 0.17 0.02 DBMET00333 0.093 0.039 DBMET00103 0.418 0.006 DBMET00104 0.577 0.004 DBMET00106 0.158 0.022 DBMET01211 0.17 0.02 DBMET01212 | DBMET00106 | |
| 0.364 | 0.007 | 0.522 | Alpha 1a adrenoreceptor antagonist | 0.111 0.032 DBMET00333 0.097 0.037 DBMET00103 0.461 0.005 DBMET00104 0.522 0.004 DBMET00106 0.126 0.028 DBMET01211 0.111 0.032 DBMET01212 | DBMET00106 | |
| 0.358 | 0.011 | 0.568 | Alpha adrenoreceptor antagonist | 0.182 0.03 DBMET00333 0.132 0.043 DBMET00103 0.491 0.006 DBMET00104 0.568 0.005 DBMET00106 0.233 0.022 DBMET01211 0.182 0.03 DBMET01212 | DBMET00106 | |
| 0.345 | 0.005 | 0.496 | Sigma receptor antagonist | 0.082 0.02 DBMET00333 0.059 0.028 DBMET00103 0.373 0.005 DBMET00104 0.496 0.004 DBMET00106 0.084 0.019 DBMET01211 0.082 0.02 DBMET01212 | DBMET00106 | |
| 0.338 | 0.004 | 0.338 | 5 Hydroxytryptamine 5 antagonist | 0.135 0.009 DBMET00333 0.136 0.009 DBMET00103 0.2 0.005 DBMET00104 0.22 0.004 DBMET00106 0.064 0.032 DBMET01211 0.135 0.009 DBMET01212 | ||
| 0.331 | 0.003 | 0.331 | Sphingosine 1-phosphate receptor 2 antagonist | 0.156 0.034 DBMET00333 0.245 0.004 DBMET00103 0.326 0.003 DBMET00104 0.166 0.024 DBMET00106 0.233 0.004 DBMET01676 0.233 0.004 DBMET00252 0.159 0.031 DBMET01211 0.156 0.034 DBMET01212 | ||
| 0.348 | 0.026 | 0.595 | 5 Hydroxytryptamine uptake stimulant | 0.358 0.023 DBMET00333 0.526 0.004 DBMET00103 0.237 0.095 DBMET00104 0.308 0.041 DBMET00106 0.595 0.003 DBMET01676 0.541 0.004 DBMET00252 0.241 0.09 DBMET01211 0.358 0.023 DBMET01212 | DBMET01676 | |
| 0.338 | 0.023 | 0.338 | P-glycoprotein inhibitor | 0.153 0.112 DBMET00333 0.194 0.068 DBMET00103 0.287 0.031 DBMET00104 0.218 0.054 DBMET00105 0.209 0.058 DBMET00106 0.235 0.046 DBMET01676 0.288 0.031 DBMET00252 0.153 0.112 DBMET01212 | ||
| 0.32 | 0.008 | 0.32 | Alpha 2b adrenoreceptor antagonist | 0.24 0.016 DBMET00333 0.25 0.014 DBMET00103 0.222 0.019 DBMET00104 0.317 0.008 DBMET00106 0.137 0.046 DBMET01211 0.24 0.016 DBMET01212 | ||
| 0.306 | 0.003 | 0.339 | Sigma 2 receptor antagonist | 0.035 0.014 DBMET00333 0.028 0.018 DBMET00103 0.339 0.003 DBMET00104 0.255 0.003 DBMET00106 0.035 0.014 DBMET01211 0.035 0.014 DBMET01212 | DBMET00104 | |
| 0.308 | 0.005 | 0.443 | Alpha 1d adrenoreceptor antagonist | 0.091 0.026 DBMET00333 0.076 0.032 DBMET00103 0.443 0.004 DBMET00104 0.377 0.004 DBMET00106 0.136 0.016 DBMET01211 0.091 0.026 DBMET01212 | DBMET00104 | |
| 0.304 | 0.005 | 0.49 | NMDA 2 receptor antagonist | 0.088 0.038 DBMET00333 0.391 0.004 DBMET00103 0.49 0.004 DBMET00104 0.095 0.035 DBMET00106 0.183 0.011 DBMET01211 0.088 0.038 DBMET01212 | DBMET00104 | |
| 0.371 | 0.077 | 0.587 | Antiobesity | 0.21 0.197 DBMET00333 0.587 0.022 DBMET00103 0.551 0.028 DBMET00104 0.299 0.116 DBMET00105 0.39 0.069 DBMET00106 0.239 0.167 DBMET01676 0.287 0.125 DBMET00252 0.403 0.064 DBMET01211 0.21 0.197 DBMET01212 | DBMET00103 | |
| 0.295 | 0.005 | 0.468 | Dopamine D4 agonist | 0.12 0.011 DBMET00333 0.073 0.022 DBMET00103 0.148 0.009 DBMET00104 0.468 0.004 DBMET00106 0.12 0.011 DBMET01212 | DBMET00106 | |
| 0.333 | 0.064 | 0.453 | Apoptosis antagonist | 0.364 0.05 DBMET00103 0.279 0.101 DBMET00104 0.395 0.04 DBMET00105 0.29 0.092 DBMET00106 0.422 0.033 DBMET01676 0.453 0.027 DBMET00252 | DBMET00252 | |
| 0.266 | 0.003 | 0.266 | Sphingosine 1-phosphate receptor 5 antagonist | 0.161 0.045 DBMET00333 0.243 0.004 DBMET00103 0.216 0.006 DBMET00104 0.171 0.032 DBMET00106 0.201 0.011 DBMET01676 0.196 0.013 DBMET00252 0.161 0.045 DBMET01212 | ||
| 0.281 | 0.024 | 0.499 | Neurotrophic factor enhancer | 0.252 0.037 DBMET00333 0.206 0.07 DBMET00103 0.195 0.082 DBMET00104 0.292 0.02 DBMET00105 0.499 0.004 DBMET00106 0.306 0.016 DBMET01676 0.269 0.029 DBMET00252 0.177 0.101 DBMET01211 0.252 0.037 DBMET01212 | DBMET00106 | |
| 0.298 | 0.044 | 0.341 | Ca(v)3.3 blocker | 0.341 0.017 DBMET00333 0.27 0.073 DBMET00104 0.338 0.019 DBMET00106 0.295 0.047 DBMET01211 0.341 0.017 DBMET01212 | DBMET01212 | |
| 0.252 | 0.005 | 0.325 | NMDA 2B receptor antagonist | 0.068 0.026 DBMET00333 0.325 0.004 DBMET00103 0.285 0.004 DBMET00104 0.06 0.031 DBMET00106 0.1 0.015 DBMET01211 0.068 0.026 DBMET01212 | DBMET00103 | |
| 0.25 | 0.005 | 0.496 | Alpha 1 adrenoreceptor agonist | 0.08 0.023 DBMET00333 0.098 0.017 DBMET00103 0.496 0.003 DBMET00104 0.384 0.004 DBMET00106 0.164 0.008 DBMET01211 0.08 0.023 DBMET01212 | DBMET00104 | |
| 0.254 | 0.019 | 0.272 | Adenylate cyclase inhibitor | 0.272 0.017 DBMET00103 0.197 0.026 DBMET00104 0.133 0.057 DBMET00105 0.117 0.07 DBMET00106 0.223 0.022 DBMET01676 0.178 0.031 DBMET00252 | DBMET00103 | |
| 0.246 | 0.018 | 0.246 | Calcium channel blocker | 0.149 0.059 DBMET00333 0.126 0.081 DBMET00103 0.23 0.021 DBMET00104 0.228 0.021 DBMET00106 0.119 0.089 DBMET01211 0.149 0.059 DBMET01212 | ||
| 0.23 | 0.004 | 0.23 | CC chemokine 3 receptor antagonist | 0.05 0.024 DBMET00333 0.072 0.016 DBMET00103 0.222 0.004 DBMET00104 0.103 0.009 DBMET00106 0.038 0.032 DBMET01211 0.05 0.024 DBMET01212 | ||
| 0.295 | 0.074 | 0.384 | Lipoxygenase inhibitor | 0.186 0.156 DBMET00333 0.241 0.106 DBMET00103 0.229 0.115 DBMET00104 0.384 0.041 DBMET01676 0.322 0.061 DBMET00252 0.186 0.156 DBMET01212 | DBMET01676 | |
| 0.223 | 0.014 | 0.254 | Alpha 2c adrenoreceptor antagonist | 0.127 0.044 DBMET00333 0.161 0.028 DBMET00103 0.254 0.01 DBMET00104 0.223 0.014 DBMET00106 0.132 0.042 DBMET01211 0.127 0.044 DBMET01212 | DBMET00104 | |
| 0.226 | 0.017 | 0.38 | Antihistaminic | 0.134 0.037 DBMET00333 0.081 0.076 DBMET00103 0.202 0.02 DBMET00104 0.38 0.007 DBMET00106 0.094 0.06 DBMET01211 0.134 0.037 DBMET01212 | DBMET00106 | |
| 0.217 | 0.017 | 0.38 | Histamine antagonist | 0.127 0.036 DBMET00333 0.183 0.022 DBMET00104 0.38 0.006 DBMET00106 0.081 0.063 DBMET01211 0.127 0.036 DBMET01212 | DBMET00106 | |
| 0.201 | 0.005 | 0.291 | Dopamine D5 antagonist | 0.077 0.013 DBMET00333 0.068 0.016 DBMET00103 0.291 0.004 DBMET00104 0.268 0.004 DBMET00106 0.172 0.005 DBMET01211 0.077 0.013 DBMET01212 | DBMET00104 | |
| 0.199 | 0.011 | 0.396 | 5 Hydroxytryptamine uptake inhibitor | 0.113 0.022 DBMET00333 0.281 0.007 DBMET00103 0.349 0.005 DBMET00104 0.056 0.049 DBMET00105 0.396 0.005 DBMET00106 0.238 0.009 DBMET01211 0.113 0.022 DBMET01212 | DBMET00106 | |
| 0.198 | 0.017 | 0.198 | Calcium channel (voltage-sensitive) blocker | 0.098 0.087 DBMET00333 0.106 0.076 DBMET00103 0.128 0.048 DBMET00104 0.169 0.025 DBMET00106 0.098 0.087 DBMET01212 | ||
| 0.185 | 0.007 | 0.185 | Amidase inhibitor | 0.156 0.009 DBMET00333 0.073 0.044 DBMET00103 0.095 0.027 DBMET00104 0.13 0.013 DBMET00106 0.11 0.019 DBMET01676 0.112 0.018 DBMET00252 0.075 0.043 DBMET01211 0.156 0.009 DBMET01212 | ||
| 0.177 | 0.013 | 0.233 | 5 Hydroxytryptamine 1F antagonist | 0.108 0.028 DBMET00333 0.144 0.018 DBMET00103 0.233 0.008 DBMET00104 0.222 0.009 DBMET00106 0.126 0.022 DBMET01211 0.108 0.028 DBMET01212 | DBMET00104 | |
| 0.233 | 0.073 | 0.258 | Neuropeptide Y2 antagonist | 0.258 0.049 DBMET00103 0.193 0.133 DBMET00104 0.191 0.136 DBMET00106 0.223 0.084 DBMET01676 0.21 0.102 DBMET00252 | DBMET00103 | |
| 0.167 | 0.012 | 0.179 | Cannabinoid receptor antagonist | 0.064 0.057 DBMET00333 0.179 0.01 DBMET00103 0.119 0.022 DBMET00104 0.065 0.055 DBMET00106 0.064 0.057 DBMET01212 | DBMET00103 | |
| 0.164 | 0.008 | 0.164 | Calcium channel L-type blocker | 0.073 0.047 DBMET00333 0.084 0.035 DBMET00103 0.117 0.017 DBMET00104 0.098 0.026 DBMET00106 0.068 0.055 DBMET01676 0.073 0.047 DBMET01212 | ||
| 0.181 | 0.028 | 0.359 | Antiadrenergic | 0.087 0.064 DBMET00333 0.092 0.061 DBMET00103 0.359 0.01 DBMET00104 0.311 0.013 DBMET00106 0.229 0.019 DBMET01211 0.087 0.064 DBMET01212 | DBMET00104 | |
| 0.157 | 0.007 | 0.157 | Cannabinoid CB2 receptor antagonist | 0.109 0.013 DBMET00103 0.118 0.011 DBMET00104 | ||
| 0.171 | 0.025 | 0.237 | 5 Hydroxytryptamine 3A agonist | 0.237 0.007 DBMET00333 0.194 0.017 DBMET00103 0.109 0.066 DBMET00104 0.22 0.01 DBMET00106 0.157 0.032 DBMET01211 0.237 0.007 DBMET01212 | DBMET01212 | |
| 0.223 | 0.078 | 0.338 | Cyclic AMP phosphodiesterase inhibitor | 0.338 0.029 DBMET00103 0.172 0.12 DBMET00104 0.267 0.056 DBMET00105 0.154 0.146 DBMET00106 0.167 0.125 DBMET01676 | DBMET00103 | |
| 0.159 | 0.014 | 0.427 | Dopamine agonist | 0.079 0.038 DBMET00333 0.083 0.035 DBMET00103 0.138 0.017 DBMET00104 0.427 0.005 DBMET00106 0.066 0.047 DBMET01211 0.079 0.038 DBMET01212 | DBMET00106 | |
| 0.173 | 0.029 | 0.353 | Adrenaline antagonist | 0.083 0.066 DBMET00333 0.087 0.063 DBMET00103 0.353 0.01 DBMET00104 0.303 0.013 DBMET00106 0.227 0.019 DBMET01211 0.083 0.066 DBMET01212 | DBMET00104 | |
| 0.191 | 0.047 | 0.349 | Acetylcholine M1 receptor antagonist | 0.189 0.047 DBMET00103 0.349 0.009 DBMET00104 0.284 0.017 DBMET00106 0.24 0.028 DBMET01211 | DBMET00104 | |
| 0.15 | 0.007 | 0.15 | Calcium channel T-type blocker | 0.055 0.045 DBMET00333 0.083 0.021 DBMET00103 0.088 0.019 DBMET00104 0.116 0.011 DBMET00106 0.055 0.045 DBMET01212 | ||
| 0.167 | 0.029 | 0.22 | Pregnane X receptor agonist | 0.143 0.066 DBMET00333 0.22 0.007 DBMET00103 0.211 0.008 DBMET00104 0.123 0.119 DBMET00106 0.13 0.099 DBMET01676 0.129 0.104 DBMET00252 0.177 0.02 DBMET01211 0.143 0.066 DBMET01212 | DBMET00103 | |
| 0.138 | 0.002 | 0.138 | GABA uptake inhibitor | 0.132 0.003 DBMET00103 0.107 0.003 DBMET00104 0.048 0.017 DBMET00106 0.077 0.005 DBMET01676 0.069 0.007 DBMET00252 | ||
| 0.175 | 0.04 | 0.237 | Neurotrophic factor | 0.162 0.05 DBMET00103 0.175 0.041 DBMET00104 0.122 0.091 DBMET00105 0.237 0.015 DBMET00106 | DBMET00106 | |
| 0.151 | 0.016 | 0.338 | Alpha adrenoreceptor agonist | 0.071 0.045 DBMET00333 0.171 0.012 DBMET00103 0.338 0.004 DBMET00104 0.268 0.005 DBMET00106 0.18 0.011 DBMET01211 0.071 0.045 DBMET01212 | DBMET00104 | |
| 0.17 | 0.039 | 0.261 | Glutamate receptor antagonist | 0.261 0.014 DBMET00103 0.168 0.04 DBMET00104 0.124 0.07 DBMET00106 | DBMET00103 | |
| 0.141 | 0.015 | 0.257 | Lanosterol 14 alpha demethylase inhibitor | 0.153 0.01 DBMET00333 0.159 0.009 DBMET00103 0.226 0.004 DBMET00104 0.129 0.022 DBMET00106 0.132 0.02 DBMET01676 0.113 0.038 DBMET00252 0.257 0.003 DBMET01211 0.153 0.01 DBMET01212 | DBMET01211 | |
| 0.135 | 0.011 | 0.293 | Adrenaline uptake inhibitor | 0.076 0.03 DBMET00333 0.293 0.004 DBMET00103 0.193 0.006 DBMET00104 0.106 0.017 DBMET00106 0.125 0.013 DBMET01211 0.076 0.03 DBMET01212 | DBMET00103 | |
| 0.137 | 0.014 | 0.137 | Histamine H2 receptor antagonist | 0.087 0.052 DBMET00333 0.091 0.045 DBMET00103 0.083 0.059 DBMET00106 0.087 0.052 DBMET01212 | ||
| 0.154 | 0.034 | 0.176 | Ca2+-transporting ATPase inhibitor | 0.137 0.085 DBMET00333 0.175 0.009 DBMET00103 0.156 0.03 DBMET00104 0.146 0.054 DBMET00105 0.137 0.085 DBMET00106 0.176 0.009 DBMET01676 0.171 0.012 DBMET00252 0.143 0.064 DBMET01211 0.137 0.085 DBMET01212 | DBMET01676 | |
| 0.126 | 0.008 | 0.181 | Neurokinin 2 antagonist | 0.181 0.004 DBMET00103 0.134 0.007 DBMET00104 | DBMET00103 | |
| 0.292 | 0.174 | 0.482 | 5 Hydroxytryptamine release inhibitor | 0.404 0.075 DBMET00333 0.374 0.095 DBMET00103 0.244 0.237 DBMET00104 0.365 0.103 DBMET00105 0.365 0.103 DBMET00106 0.482 0.039 DBMET01676 0.425 0.063 DBMET00252 0.367 0.101 DBMET01211 0.404 0.075 DBMET01212 | DBMET01676 | |
| 0.16 | 0.044 | 0.24 | Anesthetic local | 0.097 0.086 DBMET00103 0.24 0.022 DBMET00104 | DBMET00104 | |
| 0.182 | 0.066 | 0.195 | Tumour necrosis factor antagonist | 0.176 0.07 DBMET00333 0.195 0.056 DBMET00103 0.183 0.065 DBMET00106 0.187 0.062 DBMET01676 0.151 0.1 DBMET00252 0.176 0.07 DBMET01212 | DBMET00103 | |
| 0.139 | 0.025 | 0.181 | Alpha 2a adrenoreceptor antagonist | 0.071 0.057 DBMET00333 0.181 0.017 DBMET00103 0.094 0.039 DBMET00104 0.176 0.017 DBMET00106 0.071 0.057 DBMET01212 | DBMET00103 | |
| 0.127 | 0.014 | 0.154 | Leukotriene synthesis inhibitor | 0.154 0.009 DBMET00103 0.129 0.014 DBMET00104 0.131 0.013 DBMET01676 0.127 0.014 DBMET00252 | DBMET00103 | |
| 0.121 | 0.009 | 0.121 | Melanin-concentrating hormone receptor 1 antagonist | 0.087 0.018 DBMET00333 0.061 0.029 DBMET00103 0.108 0.011 DBMET00106 0.087 0.018 DBMET01212 | ||
| 0.154 | 0.042 | 0.272 | Cholesterol synthesis inhibitor | 0.121 0.064 DBMET00333 0.127 0.059 DBMET00103 0.181 0.032 DBMET00104 0.123 0.063 DBMET00105 0.123 0.063 DBMET00106 0.255 0.017 DBMET01676 0.272 0.015 DBMET00252 0.156 0.042 DBMET01211 0.121 0.064 DBMET01212 | DBMET00252 | |
| 0.156 | 0.045 | 0.168 | Farnesoid X receptor antagonist | 0.167 0.037 DBMET00103 0.164 0.039 DBMET00104 0.168 0.036 DBMET01676 0.164 0.039 DBMET00252 0.129 0.084 DBMET01211 | DBMET01676 | |
| 0.147 | 0.039 | 0.19 | 5-Lipoxygenase inhibitor | 0.142 0.041 DBMET00103 0.118 0.051 DBMET00104 0.19 0.026 DBMET01676 0.158 0.035 DBMET00252 | DBMET01676 | |
| 0.119 | 0.013 | 0.182 | Sphingosine 1-phosphate receptor antagonist | 0.074 0.059 DBMET00333 0.104 0.019 DBMET00103 0.147 0.006 DBMET00104 0.144 0.007 DBMET01676 0.182 0.005 DBMET00252 0.093 0.026 DBMET01211 0.074 0.059 DBMET01212 | DBMET00252 | |
| 0.239 | 0.136 | 0.574 | Vasodilator, peripheral | 0.21 0.164 DBMET00333 0.225 0.149 DBMET00103 0.214 0.16 DBMET00104 0.249 0.128 DBMET00105 0.289 0.102 DBMET00106 0.574 0.019 DBMET01676 0.465 0.036 DBMET00252 0.199 0.178 DBMET01211 0.21 0.164 DBMET01212 | DBMET01676 | |
| 0.108 | 0.006 | 0.156 | Nicotinic alpha3beta2 receptor antagonist | 0.118 0.005 DBMET00333 0.116 0.005 DBMET00103 0.156 0.004 DBMET00106 0.056 0.031 DBMET01676 0.066 0.021 DBMET00252 0.118 0.005 DBMET01212 | DBMET00106 | |
| 0.106 | 0.006 | 0.133 | Sigma 1 receptor antagonist | 0.026 0.019 DBMET00333 0.103 0.006 DBMET00104 0.133 0.005 DBMET00106 0.026 0.019 DBMET01212 | DBMET00106 | |
| 0.103 | 0.006 | 0.12 | MDM2 inhibitor | 0.073 0.032 DBMET00333 0.12 0.004 DBMET00103 0.085 0.015 DBMET00104 0.067 0.049 DBMET00106 0.096 0.009 DBMET01676 0.092 0.01 DBMET00252 0.073 0.032 DBMET01212 | DBMET00103 | |
| 0.247 | 0.151 | 0.375 | Calcium channel activator | 0.25 0.147 DBMET00333 0.375 0.035 DBMET00103 0.344 0.054 DBMET00104 0.251 0.146 DBMET00106 0.246 0.152 DBMET01676 0.341 0.056 DBMET01211 0.25 0.147 DBMET01212 | DBMET00103 | |
| 0.115 | 0.02 | 0.115 | Estrogen receptor alpha antagonist | 0.083 0.044 DBMET00103 0.106 0.024 DBMET00104 0.09 0.035 DBMET00106 0.085 0.042 DBMET01676 0.082 0.046 DBMET00252 | ||
| 0.1 | 0.006 | 0.209 | Nociceptin (N/OFQ) receptor antagonist | 0.209 0.004 DBMET00103 0.106 0.005 DBMET00104 | DBMET00103 | |
| 0.107 | 0.014 | 0.136 | Cannabinoid CB1 receptor antagonist | 0.059 0.045 DBMET00333 0.136 0.009 DBMET00103 0.081 0.026 DBMET00104 0.06 0.045 DBMET00106 0.059 0.045 DBMET01212 | DBMET00103 | |
| 0.117 | 0.025 | 0.18 | Opioid kappa receptor antagonist | 0.18 0.012 DBMET00103 0.103 0.032 DBMET00104 | DBMET00103 | |
| 0.164 | 0.076 | 0.318 | Sigma receptor agonist | 0.135 0.098 DBMET00104 0.318 0.036 DBMET00106 | DBMET00106 | |
| 0.123 | 0.039 | 0.182 | Creatine kinase inhibitor | 0.115 0.045 DBMET00333 0.143 0.027 DBMET00103 0.107 0.052 DBMET00104 0.115 0.045 DBMET00106 0.182 0.014 DBMET01676 0.151 0.023 DBMET00252 0.117 0.043 DBMET01211 0.115 0.045 DBMET01212 | DBMET01676 | |
| 0.137 | 0.053 | 0.243 | Acetylcholine muscarinic antagonist | 0.115 0.073 DBMET00103 0.243 0.016 DBMET00104 0.212 0.021 DBMET00106 0.159 0.039 DBMET01211 | DBMET00104 | |
| 0.11 | 0.027 | 0.22 | Analgesic, opioid | 0.22 0.008 DBMET00103 0.109 0.027 DBMET00104 | DBMET00103 | |
| 0.119 | 0.037 | 0.186 | Opioid antagonist | 0.186 0.017 DBMET00103 0.107 0.043 DBMET00104 | DBMET00103 | |
| 0.086 | 0.004 | 0.103 | Nerve growth factor antagonist | 0.041 0.032 DBMET00333 0.103 0.003 DBMET00103 0.075 0.005 DBMET00104 0.083 0.004 DBMET00106 0.041 0.032 DBMET01212 | DBMET00103 | |
| 0.097 | 0.016 | 0.129 | Phospholipase D inhibitor | 0.115 0.008 DBMET00333 0.1 0.014 DBMET00103 0.096 0.017 DBMET00104 0.113 0.008 DBMET00106 0.122 0.006 DBMET01676 0.129 0.005 DBMET00252 0.112 0.009 DBMET01211 0.115 0.008 DBMET01212 | DBMET00252 | |
| 0.089 | 0.01 | 0.091 | CC chemokine 5 receptor antagonist | 0.078 0.014 DBMET00103 0.091 0.01 DBMET00104 | DBMET00104 | |
| 0.092 | 0.015 | 0.092 | Potassium channel (Tandem pore domain) blocker | 0.076 0.046 DBMET00333 0.077 0.041 DBMET00103 0.077 0.041 DBMET00104 0.086 0.022 DBMET00106 0.078 0.039 DBMET01676 0.07 0.063 DBMET00252 0.076 0.046 DBMET01212 | ||
| 0.107 | 0.033 | 0.253 | Glutamate receptor agonist | 0.2 0.01 DBMET00333 0.114 0.029 DBMET00106 0.247 0.007 DBMET01676 0.253 0.007 DBMET00252 0.068 0.065 DBMET01211 0.2 0.01 DBMET01212 | DBMET00252 | |
| 0.085 | 0.011 | 0.085 | Potassium channel Kv1.3 blocker | 0.051 0.029 DBMET00333 0.056 0.024 DBMET00103 0.067 0.017 DBMET00104 0.051 0.029 DBMET01212 | ||
| 0.195 | 0.123 | 0.467 | Superoxide dismutase inhibitor | 0.212 0.104 DBMET00333 0.252 0.073 DBMET00103 0.251 0.074 DBMET00106 0.467 0.016 DBMET01676 0.394 0.028 DBMET00252 0.212 0.104 DBMET01212 | DBMET01676 | |
| 0.088 | 0.017 | 0.222 | NMDA 2A receptor antagonist | 0.222 0.004 DBMET00103 0.176 0.005 DBMET00104 0.091 0.016 DBMET01211 | DBMET00103 | |
| 0.078 | 0.008 | 0.214 | Substance P antagonist | 0.214 0.004 DBMET00103 0.121 0.005 DBMET00104 | DBMET00103 | |
| 0.085 | 0.017 | 0.111 | CC chemokine 2 receptor antagonist | 0.111 0.011 DBMET00103 0.103 0.013 DBMET00104 | DBMET00103 | |
| 0.088 | 0.021 | 0.257 | Acetylcholine M5 receptor antagonist | 0.063 0.038 DBMET00333 0.071 0.03 DBMET00103 0.257 0.004 DBMET00104 0.195 0.005 DBMET00106 0.182 0.005 DBMET01211 0.063 0.038 DBMET01212 | DBMET00104 | |
| 0.08 | 0.013 | 0.259 | 5 Hydroxytryptamine 7 agonist | 0.196 0.004 DBMET00333 0.068 0.021 DBMET00103 0.259 0.003 DBMET00106 0.06 0.032 DBMET01211 0.196 0.004 DBMET01212 | DBMET00106 | |
| 0.168 | 0.102 | 0.34 | Psychostimulant | 0.184 0.09 DBMET00333 0.34 0.033 DBMET00103 0.181 0.092 DBMET00104 0.168 0.101 DBMET00105 0.161 0.107 DBMET00106 0.223 0.069 DBMET01676 0.159 0.109 DBMET00252 0.199 0.08 DBMET01211 0.184 0.09 DBMET01212 | DBMET00103 | |
| 0.069 | 0.003 | 0.075 | Ceramide glucosyltransferase inhibitor | 0.068 0.004 DBMET00333 0.04 0.017 DBMET00103 0.072 0.003 DBMET00104 0.065 0.004 DBMET00105 0.071 0.003 DBMET00106 0.055 0.005 DBMET01676 0.056 0.005 DBMET00252 0.075 0.003 DBMET01211 0.068 0.004 DBMET01212 | DBMET01211 | |
| 0.178 | 0.116 | 0.382 | Antiamyloidogenic | 0.292 0.054 DBMET00333 0.236 0.078 DBMET00104 0.212 0.092 DBMET00105 0.191 0.106 DBMET00106 0.268 0.063 DBMET01676 0.318 0.046 DBMET00252 0.382 0.032 DBMET01211 0.292 0.054 DBMET01212 | DBMET01211 | |
| 0.113 | 0.051 | 0.151 | Toll-Like receptor 4 antagonist | 0.108 0.058 DBMET00333 0.118 0.045 DBMET00103 0.117 0.047 DBMET00104 0.151 0.02 DBMET00105 0.136 0.03 DBMET01676 0.119 0.044 DBMET00252 0.118 0.046 DBMET01211 0.108 0.058 DBMET01212 | DBMET00105 | |
| 0.104 | 0.045 | 0.182 | Alpha 2 adrenoreceptor antagonist | 0.085 0.061 DBMET00333 0.133 0.032 DBMET00103 0.121 0.036 DBMET00104 0.182 0.02 DBMET00106 0.085 0.061 DBMET01211 0.085 0.061 DBMET01212 | DBMET00106 | |
| 0.093 | 0.034 | 0.19 | Acetylcholine M4 receptor antagonist | 0.084 0.042 DBMET00333 0.099 0.029 DBMET00103 0.108 0.023 DBMET00104 0.19 0.006 DBMET00106 0.088 0.038 DBMET01211 0.084 0.042 DBMET01212 | DBMET00106 | |
| 0.092 | 0.035 | 0.152 | Opioid mu receptor antagonist | 0.152 0.017 DBMET00103 0.08 0.04 DBMET00104 | DBMET00103 | |
| 0.157 | 0.1 | 0.436 | Succinate dehydrogenase inhibitor | 0.208 0.043 DBMET00333 0.214 0.039 DBMET00103 0.149 0.114 DBMET00106 0.436 0.004 DBMET01676 0.4 0.004 DBMET00252 0.147 0.118 DBMET01211 0.208 0.043 DBMET01212 | DBMET01676 | |
| 0.07 | 0.014 | 0.348 | NMDA receptor subunit 3A antagonist | 0.348 0.003 DBMET00103 0.125 0.006 DBMET00104 0.035 0.03 DBMET01676 | DBMET00103 | |
| 0.081 | 0.028 | 0.081 | Cannabinoid CB1 receptor agonist | 0.066 0.038 DBMET00103 0.062 0.041 DBMET00104 | ||
| 0.091 | 0.039 | 0.166 | Nicotinic alpha4beta2 receptor antagonist | 0.166 0.005 DBMET00333 0.116 0.02 DBMET00103 0.154 0.007 DBMET00106 0.068 0.064 DBMET01676 0.074 0.057 DBMET00252 0.122 0.016 DBMET01211 0.166 0.005 DBMET01212 | DBMET01212 | |
| 0.088 | 0.036 | 0.089 | Viral attachment inhibitor | 0.089 0.034 DBMET00103 0.073 0.066 DBMET00104 | DBMET00103 | |
| 0.195 | 0.144 | 0.377 | Tyrosine 3 hydroxylase inhibitor | 0.362 0.014 DBMET00103 0.209 0.121 DBMET00106 0.377 0.011 DBMET01676 0.353 0.015 DBMET00252 | DBMET01676 | |
| 0.128 | 0.078 | 0.224 | Interleukin 1 antagonist | 0.217 0.027 DBMET00333 0.112 0.101 DBMET00103 0.224 0.025 DBMET00106 0.206 0.03 DBMET01676 0.174 0.045 DBMET00252 0.148 0.059 DBMET01211 0.217 0.027 DBMET01212 | DBMET00106 | |
| 0.077 | 0.027 | 0.246 | NMDA 2C receptor antagonist | 0.246 0.004 DBMET00103 0.116 0.011 DBMET00104 0.069 0.034 DBMET01676 0.055 0.053 DBMET00252 | DBMET00103 | |
| 0.067 | 0.022 | 0.11 | Dopamine transporter inhibitor | 0.046 0.036 DBMET00333 0.11 0.01 DBMET00103 0.093 0.013 DBMET00104 0.081 0.017 DBMET00106 0.067 0.022 DBMET01211 0.046 0.036 DBMET01212 | DBMET00103 | |
| 0.1 | 0.055 | 0.261 | HIV-1 integrase (Overall Integration) inhibitor | 0.149 0.026 DBMET00333 0.191 0.013 DBMET00103 0.158 0.023 DBMET00106 0.261 0.004 DBMET01676 0.234 0.006 DBMET00252 0.112 0.045 DBMET01211 0.149 0.026 DBMET01212 | DBMET01676 | |
| 0.095 | 0.051 | 0.123 | Histamine N-methyltransferase inhibitor | 0.106 0.041 DBMET00333 0.102 0.044 DBMET00103 0.123 0.028 DBMET00106 0.106 0.041 DBMET01212 | DBMET00106 | |
| 0.086 | 0.043 | 0.12 | Interferon agonist | 0.075 0.061 DBMET00103 0.091 0.037 DBMET00105 0.12 0.017 DBMET01676 0.101 0.028 DBMET00252 | DBMET01676 | |
| 0.113 | 0.069 | 0.113 | Estrogen antagonist | 0.104 0.088 DBMET00104 0.103 0.091 DBMET00106 0.101 0.097 DBMET01676 | ||
| 0.061 | 0.017 | 0.079 | Adenylate cyclase 1 inhibitor | 0.079 0.008 DBMET00103 0.047 0.03 DBMET00104 0.052 0.025 DBMET00106 0.048 0.029 DBMET01676 | DBMET00103 | |
| 0.182 | 0.139 | 0.642 | 5 Hydroxytryptamine release stimulant | 0.202 0.119 DBMET00333 0.642 0.011 DBMET00103 0.176 0.145 DBMET00104 0.17 0.152 DBMET00105 0.565 0.018 DBMET00106 0.323 0.063 DBMET01676 0.211 0.112 DBMET00252 0.194 0.127 DBMET01211 0.202 0.119 DBMET01212 | DBMET00103 | |
| 0.065 | 0.022 | 0.142 | Neurokinin antagonist | 0.142 0.005 DBMET00103 0.103 0.01 DBMET00104 | DBMET00103 | |
| 0.063 | 0.021 | 0.116 | 5 Hydroxytryptamine 4 antagonist | 0.061 0.023 DBMET00333 0.116 0.005 DBMET00106 0.061 0.023 DBMET01212 | DBMET00106 | |
| 0.153 | 0.111 | 0.446 | Non-steroidal antiinflammatory agent | 0.206 0.066 DBMET00333 0.186 0.082 DBMET00104 0.309 0.026 DBMET00105 0.153 0.112 DBMET00106 0.446 0.009 DBMET01676 0.445 0.009 DBMET00252 0.25 0.043 DBMET01211 0.206 0.066 DBMET01212 | DBMET01676 | |
| 0.196 | 0.155 | 0.358 | Gastrin inhibitor | 0.188 0.167 DBMET00333 0.218 0.122 DBMET00103 0.188 0.167 DBMET00106 0.358 0.009 DBMET01676 0.337 0.014 DBMET00252 0.188 0.167 DBMET01212 | DBMET01676 | |
| 0.077 | 0.036 | 0.096 | Acetylcholine M5 receptor agonist | 0.093 0.024 DBMET00333 0.096 0.022 DBMET00106 0.06 0.056 DBMET01676 0.06 0.056 DBMET00252 0.093 0.024 DBMET01212 | DBMET00106 | |
| 0.18 | 0.139 | 0.299 | Cardiotonic | 0.299 0.056 DBMET00104 0.176 0.144 DBMET01211 | DBMET00104 | |
| 0.05 | 0.011 | 0.06 | Delayed rectifier potassium channel blocker | 0.049 0.012 DBMET00333 0.06 0.007 DBMET00106 0.049 0.012 DBMET01212 | DBMET00106 | |
| 0.063 | 0.024 | 0.324 | 5 Hydroxytryptamine 1A agonist | 0.049 0.029 DBMET00333 0.067 0.023 DBMET00104 0.324 0.005 DBMET00106 0.042 0.036 DBMET01211 0.049 0.029 DBMET01212 | DBMET00106 | |
| 0.151 | 0.113 | 0.353 | Anesthetic general | 0.206 0.071 DBMET00103 0.155 0.109 DBMET00104 0.164 0.1 DBMET00105 0.14 0.125 DBMET00106 0.353 0.023 DBMET01676 0.306 0.032 DBMET00252 | DBMET01676 | |
| 0.058 | 0.02 | 0.058 | Cholesterol esterase inhibitor | 0.049 0.032 DBMET00103 0.044 0.041 DBMET00104 0.055 0.023 DBMET00106 | ||
| 0.096 | 0.058 | 0.477 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.146 0.028 DBMET00333 0.149 0.027 DBMET00103 0.14 0.03 DBMET00105 0.093 0.062 DBMET00106 0.477 0.003 DBMET01676 0.41 0.004 DBMET00252 0.101 0.053 DBMET01211 0.146 0.028 DBMET01212 | DBMET01676 | |
| 0.073 | 0.035 | 0.243 | CDC25B inhibitor | 0.106 0.014 DBMET00333 0.076 0.031 DBMET00106 0.243 0.004 DBMET01676 0.204 0.005 DBMET00252 0.106 0.014 DBMET01212 | DBMET01676 | |
| 0.148 | 0.111 | 0.312 | Catenin beta inhibitor | 0.149 0.109 DBMET00333 0.167 0.071 DBMET00103 0.149 0.109 DBMET00106 0.287 0.006 DBMET01676 0.312 0.005 DBMET00252 0.149 0.109 DBMET01212 | DBMET00252 | |
| 0.106 | 0.07 | 0.313 | Cystathionine beta-synthase inhibitor | 0.172 0.032 DBMET00333 0.149 0.041 DBMET00103 0.313 0.009 DBMET01676 0.266 0.013 DBMET00252 0.172 0.032 DBMET01212 | DBMET01676 | |
| 0.084 | 0.05 | 0.122 | CC chemokine 5 receptor agonist | 0.083 0.054 DBMET00103 0.122 0.008 DBMET00106 | DBMET00106 | |
| 0.049 | 0.015 | 0.082 | Heme oxygenase inhibitor | 0.073 0.004 DBMET00333 0.054 0.009 DBMET00104 0.061 0.005 DBMET00106 0.048 0.016 DBMET01676 0.043 0.029 DBMET00252 0.082 0.004 DBMET01211 0.073 0.004 DBMET01212 | DBMET01211 | |
| 0.041 | 0.009 | 0.4 | Kynurenine 3 monooxygenase inhibitor | 0.126 0.003 DBMET00333 0.05 0.007 DBMET00106 0.304 0.002 DBMET01676 0.4 0.002 DBMET00252 0.043 0.008 DBMET01211 0.126 0.003 DBMET01212 | DBMET00252 | |
| 0.115 | 0.083 | 0.241 | Acetylcholinesterase inhibitor | 0.241 0.023 DBMET00333 0.183 0.039 DBMET00106 0.241 0.023 DBMET01212 | DBMET01212 | |
| 0.273 | 0.242 | 0.629 | Antiinflammatory | 0.324 0.193 DBMET00103 0.35 0.173 DBMET00104 0.629 0.046 DBMET00105 0.494 0.09 DBMET01676 0.499 0.088 DBMET00252 0.27 0.245 DBMET01211 | DBMET00105 | |
| 0.115 | 0.085 | 0.195 | Cyclooxygenase 1 inhibitor | 0.102 0.097 DBMET00333 0.195 0.036 DBMET01676 0.194 0.037 DBMET00252 0.102 0.097 DBMET01212 | DBMET01676 | |
| 0.074 | 0.044 | 0.196 | HIV-1 integrase inhibitor | 0.102 0.024 DBMET00333 0.075 0.042 DBMET00106 0.196 0.005 DBMET01676 0.186 0.005 DBMET00252 0.102 0.024 DBMET01212 | DBMET01676 | |
| 0.078 | 0.05 | 0.361 | GABA aminotransferase inhibitor | 0.084 0.042 DBMET00103 0.081 0.045 DBMET00105 0.361 0.003 DBMET01676 0.242 0.004 DBMET00252 | DBMET01676 | |
| 0.11 | 0.083 | 0.208 | Cholinergic antagonist | 0.116 0.078 DBMET00333 0.111 0.082 DBMET00103 0.175 0.04 DBMET00104 0.208 0.03 DBMET00106 0.177 0.039 DBMET01211 0.116 0.078 DBMET01212 | DBMET00106 | |
| 0.068 | 0.04 | 0.152 | 5 Hydroxytryptamine 1D antagonist | 0.068 0.04 DBMET00103 0.152 0.012 DBMET00106 | DBMET00106 | |
| 0.156 | 0.131 | 0.355 | Hypolipemic | 0.335 0.039 DBMET00104 0.22 0.082 DBMET00105 0.355 0.034 DBMET01676 0.322 0.042 DBMET00252 0.286 0.053 DBMET01211 | DBMET01676 | |
| 0.063 | 0.038 | 0.202 | Acetylcholine M3 receptor antagonist | 0.062 0.039 DBMET00103 0.202 0.007 DBMET00104 0.102 0.018 DBMET00106 0.09 0.022 DBMET01211 | DBMET00104 | |
| 0.107 | 0.083 | 0.205 | Acetylcholine antagonist | 0.111 0.079 DBMET00333 0.109 0.081 DBMET00103 0.173 0.039 DBMET00104 0.205 0.029 DBMET00106 0.172 0.039 DBMET01211 0.111 0.079 DBMET01212 | DBMET00106 | |
| 0.057 | 0.033 | 0.173 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.069 0.022 DBMET00333 0.058 0.032 DBMET00106 0.135 0.006 DBMET01676 0.173 0.004 DBMET00252 0.069 0.022 DBMET01212 | DBMET00252 | |
| 0.039 | 0.016 | 0.04 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.04 0.015 DBMET00103 | DBMET00103 | |
| 0.039 | 0.018 | 0.237 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.105 0.004 DBMET00333 0.053 0.008 DBMET00106 0.234 0.003 DBMET01676 0.237 0.003 DBMET00252 0.105 0.004 DBMET01212 | DBMET00252 | |
| 0.05 | 0.029 | 0.061 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.061 0.023 DBMET00103 | DBMET00103 | |
| 0.099 | 0.079 | 0.215 | DOPA decarboxylase inhibitor | 0.1 0.076 DBMET00333 0.118 0.048 DBMET00103 0.102 0.072 DBMET00106 0.215 0.005 DBMET01676 0.2 0.006 DBMET00252 0.1 0.076 DBMET01212 | DBMET01676 | |
| 0.057 | 0.037 | 0.088 | Leukotriene C antagonist | 0.053 0.051 DBMET00103 0.064 0.021 DBMET00104 0.085 0.006 DBMET01676 0.088 0.005 DBMET00252 0.054 0.046 DBMET01211 | DBMET00252 | |
| 0.032 | 0.012 | 0.032 | DNA polymerase III inhibitor | 0.03 0.015 DBMET00103 0.032 0.012 DBMET00104 0.026 0.025 DBMET00106 | ||
| 0.043 | 0.025 | 0.102 | Neurokinin 1 antagonist | 0.102 0.006 DBMET00103 0.076 0.01 DBMET00104 | DBMET00103 | |
| 0.037 | 0.022 | 0.103 | Glutamate (mGluR group II) agonist | 0.088 0.008 DBMET00333 0.041 0.02 DBMET00106 0.103 0.007 DBMET01676 0.083 0.009 DBMET00252 0.088 0.008 DBMET01212 | DBMET01676 | |
| 0.07 | 0.056 | 0.209 | CDC25A inhibitor | 0.09 0.034 DBMET00333 0.066 0.064 DBMET00106 0.209 0.006 DBMET01676 0.192 0.008 DBMET00252 0.09 0.034 DBMET01212 | DBMET01676 | |
| 0.051 | 0.037 | 0.304 | 5 Hydroxytryptamine 1 agonist | 0.043 0.042 DBMET00333 0.043 0.042 DBMET00104 0.304 0.006 DBMET00106 0.043 0.042 DBMET01212 | DBMET00106 | |
| 0.027 | 0.013 | 0.096 | Prostaglandin EP2 agonist | 0.068 0.004 DBMET00104 0.096 0.003 DBMET01676 0.09 0.003 DBMET00252 0.053 0.005 DBMET01211 | DBMET01676 | |
| 0.038 | 0.024 | 0.053 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.039 0.022 DBMET00333 0.053 0.01 DBMET00106 0.033 0.032 DBMET01211 0.039 0.022 DBMET01212 | DBMET00106 | |
| 0.028 | 0.015 | 0.039 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.039 0.005 DBMET00103 0.028 0.015 DBMET00104 | DBMET00103 | |
| 0.033 | 0.022 | 0.086 | Glutamate (mGluR2) agonist | 0.086 0.008 DBMET00333 0.038 0.019 DBMET00106 0.085 0.008 DBMET01676 0.065 0.01 DBMET00252 0.086 0.008 DBMET01212 | DBMET01212 | |
| 0.043 | 0.032 | 0.094 | Nicotinic receptor alpha3 subunit antagonist | 0.094 0.01 DBMET00333 0.046 0.028 DBMET00103 0.073 0.014 DBMET00106 0.039 0.038 DBMET00252 0.094 0.01 DBMET01212 | DBMET01212 | |
| 0.045 | 0.034 | 0.115 | Glycine transporter 2 inhibitor | 0.115 0.011 DBMET01676 0.093 0.014 DBMET00252 | DBMET01676 | |
| 0.022 | 0.011 | 0.033 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.033 0.004 DBMET00103 0.021 0.013 DBMET00104 | DBMET00103 | |
| 0.06 | 0.049 | 0.06 | Cannabinoid receptor agonist | 0.056 0.052 DBMET00103 | ||
| 0.071 | 0.061 | 0.103 | Vanilloid 4 agonist | 0.103 0.015 DBMET00103 0.069 0.068 DBMET00104 0.103 0.015 DBMET01676 0.093 0.022 DBMET00252 | DBMET01676 | |
| 0.077 | 0.069 | 0.12 | Ca(v)3.1 blocker | 0.12 0.011 DBMET00106 | DBMET00106 | |
| 0.089 | 0.081 | 0.181 | Nitric-oxide synthase inhibitor | 0.181 0.013 DBMET00103 0.095 0.069 DBMET00104 0.088 0.082 DBMET01676 0.105 0.053 DBMET00252 | DBMET00103 | |
| 0.041 | 0.033 | 0.283 | NMDA receptor subunit 3B antagonist | 0.283 0.004 DBMET00103 0.057 0.02 DBMET00104 0.043 0.031 DBMET01676 | DBMET00103 | |
| 0.014 | 0.007 | 0.014 | DNA polymerase III polC-type inhibitor | 0.014 0.008 DBMET00103 0.014 0.007 DBMET00104 | ||
| 0.077 | 0.07 | 0.126 | Androgen antagonist | 0.126 0.03 DBMET00103 0.102 0.045 DBMET00104 0.088 0.057 DBMET01676 0.08 0.065 DBMET00252 | DBMET00103 | |
| 0.021 | 0.015 | 0.071 | Nociceptin (N/OFQ) receptor agonist | 0.071 0.005 DBMET00103 0.022 0.014 DBMET00104 | DBMET00103 | |
| 0.155 | 0.149 | 0.382 | Vasodilator | 0.174 0.127 DBMET00104 0.382 0.026 DBMET00105 0.246 0.071 DBMET01676 0.166 0.135 DBMET00252 | DBMET00105 | |
| 0.117 | 0.113 | 0.231 | Cholinergic | 0.231 0.034 DBMET00333 0.195 0.049 DBMET00106 0.231 0.034 DBMET01212 | DBMET01212 | |
| 0.039 | 0.035 | 0.159 | Histamine H3 receptor antagonist | 0.04 0.034 DBMET00333 0.159 0.007 DBMET00106 0.04 0.034 DBMET01212 | DBMET00106 | |
| 0.181 | 0.177 | 0.268 | Hypoxia-inducible factor 1 alpha inhibitor | 0.222 0.127 DBMET00103 0.216 0.134 DBMET00104 0.192 0.161 DBMET00106 0.268 0.085 DBMET01676 0.217 0.133 DBMET00252 0.191 0.164 DBMET01211 | DBMET01676 | |
| 0.073 | 0.07 | 0.156 | Glycine receptor antagonist | 0.156 0.006 DBMET00103 0.082 0.053 DBMET00105 0.113 0.022 DBMET01676 0.089 0.044 DBMET00252 | DBMET00103 | |
| 0.053 | 0.051 | 0.086 | Pregnane X receptor antagonist | 0.057 0.04 DBMET00333 0.065 0.021 DBMET00103 0.063 0.024 DBMET00104 0.086 0.005 DBMET01676 0.082 0.005 DBMET00252 0.068 0.016 DBMET01211 0.057 0.04 DBMET01212 | DBMET01676 | |
| 0.046 | 0.045 | 0.12 | Opioid agonist | 0.12 0.01 DBMET00103 | DBMET00103 | |
| 0.021 | 0.019 | 0.124 | Prostaglandin E2 agonist | 0.086 0.004 DBMET00104 0.122 0.004 DBMET01676 0.124 0.004 DBMET00252 0.093 0.004 DBMET01211 | DBMET00252 | |
| 0.252 | 0.251 | 0.507 | Caspase 9 stimulant | 0.393 0.115 DBMET00103 0.267 0.232 DBMET00105 0.478 0.069 DBMET01676 0.507 0.057 DBMET00252 | DBMET00252 | |
| 0.027 | 0.027 | 0.158 | Prostaglandin agonist | 0.097 0.005 DBMET00104 0.156 0.004 DBMET01676 0.158 0.004 DBMET00252 0.101 0.005 DBMET01211 | DBMET00252 | |
| 0.058 | 0.057 | 0.356 | 5 Hydroxytryptamine agonist | 0.081 0.041 DBMET00333 0.098 0.034 DBMET00103 0.356 0.006 DBMET00106 0.081 0.041 DBMET01212 | DBMET00106 | |
| 0.054 | 0.055 | 0.083 | Potassium channel intermediate-conductance Ca-activated blocker | 0.062 0.038 DBMET00333 0.083 0.016 DBMET00106 0.078 0.019 DBMET01676 0.082 0.016 DBMET00252 0.062 0.038 DBMET01212 | DBMET00106 | |
| 0.036 | 0.039 | 0.062 | Leukotriene C4 antagonist | 0.042 0.02 DBMET00104 0.059 0.006 DBMET01676 0.062 0.005 DBMET00252 | DBMET00252 | |
| 0.036 | 0.039 | 0.064 | Thymidine kinase inhibitor | 0.064 0.012 DBMET00103 0.038 0.033 DBMET00104 | DBMET00103 | |
| 0.026 | 0.03 | 0.145 | Lysophosphatidic acid 2 receptor antagonist | 0.043 0.011 DBMET00104 0.145 0.004 DBMET01676 0.105 0.004 DBMET00252 0.04 0.012 DBMET01211 | DBMET01676 | |
| 0.103 | 0.107 | 0.156 | Sodium channel blocker | 0.114 0.092 DBMET00333 0.156 0.055 DBMET00103 0.137 0.068 DBMET00104 0.132 0.072 DBMET00106 0.122 0.082 DBMET01211 0.114 0.092 DBMET01212 | DBMET00103 | |
| 0.081 | 0.086 | 0.175 | Glutamate release inhibitor | 0.099 0.044 DBMET00333 0.091 0.06 DBMET00103 0.089 0.063 DBMET00104 0.098 0.045 DBMET00105 0.097 0.047 DBMET00106 0.152 0.009 DBMET01676 0.175 0.006 DBMET00252 0.108 0.033 DBMET01211 0.099 0.044 DBMET01212 | DBMET00252 | |
| 0.058 | 0.063 | 0.093 | Beta 3 adrenoreceptor antagonist | 0.093 0.017 DBMET00103 0.08 0.023 DBMET00104 0.059 0.058 DBMET01676 0.067 0.038 DBMET01211 | DBMET00103 | |
| 0.027 | 0.034 | 0.06 | Catechol O-methyltransferase inhibitor | 0.06 0.007 DBMET01676 0.049 0.009 DBMET00252 | DBMET01676 | |
| 0.048 | 0.056 | 0.12 | Opioid delta receptor antagonist | 0.12 0.026 DBMET00103 | DBMET00103 | |
| 0.035 | 0.043 | 0.106 | Purinergic P2Y antagonist | 0.106 0.009 DBMET01676 0.105 0.009 DBMET00252 | DBMET01676 | |
| 0.089 | 0.097 | 0.182 | Interleukin 1b antagonist | 0.131 0.054 DBMET00333 0.182 0.024 DBMET00106 0.149 0.041 DBMET01676 0.138 0.049 DBMET00252 0.102 0.079 DBMET01211 0.131 0.054 DBMET01212 | DBMET00106 | |
| 0.03 | 0.04 | 0.054 | Dopamine D3 agonist | 0.054 0.017 DBMET00106 | DBMET00106 | |
| 0.163 | 0.174 | 0.269 | 5 Hydroxytryptamine 1E antagonist | 0.264 0.06 DBMET00333 0.219 0.109 DBMET00103 0.269 0.055 DBMET00106 0.249 0.076 DBMET01211 0.264 0.06 DBMET01212 | DBMET00106 | |
| 0.048 | 0.059 | 0.126 | Glutamate (mGluR) agonist | 0.1 0.023 DBMET00333 0.06 0.045 DBMET00106 0.115 0.019 DBMET01676 0.126 0.017 DBMET00252 0.1 0.023 DBMET01212 | DBMET00252 | |
| 0.057 | 0.069 | 0.071 | Potassium channel (ATP-sensitive) blocker | 0.066 0.047 DBMET00333 0.071 0.039 DBMET01676 0.065 0.051 DBMET00252 0.066 0.047 DBMET01212 | DBMET01676 | |
| 0.138 | 0.15 | 0.265 | Insulin sensitizer | 0.179 0.096 DBMET00103 0.185 0.089 DBMET00104 0.265 0.027 DBMET01676 0.253 0.033 DBMET00252 0.172 0.105 DBMET01211 | DBMET01676 | |
| 0.047 | 0.059 | 0.148 | Sphingosine 1-phosphate receptor 5 agonist | 0.051 0.045 DBMET00333 0.057 0.03 DBMET00106 0.148 0.005 DBMET01676 0.139 0.005 DBMET00252 0.051 0.045 DBMET01212 | DBMET01676 | |
| 0.09 | 0.102 | 0.259 | MAO inhibitor | 0.259 0.026 DBMET00333 0.252 0.027 DBMET00106 0.096 0.095 DBMET01676 0.104 0.087 DBMET00252 0.105 0.085 DBMET01211 0.259 0.026 DBMET01212 | DBMET01212 | |
| 0.099 | 0.113 | 0.173 | Sodium channel (voltage-gated) blocker | 0.129 0.074 DBMET00333 0.173 0.041 DBMET00103 0.133 0.07 DBMET00104 0.117 0.088 DBMET00106 0.138 0.064 DBMET01211 0.129 0.074 DBMET01212 | DBMET00103 | |
| 0.067 | 0.081 | 0.176 | GABA B receptor agonist | 0.082 0.038 DBMET00333 0.118 0.008 DBMET00103 0.176 0.004 DBMET01676 0.145 0.004 DBMET00252 0.081 0.039 DBMET01211 0.082 0.038 DBMET01212 | DBMET01676 | |
| 0.12 | 0.135 | 0.274 | Interferon gamma antagonist | 0.143 0.088 DBMET00103 0.127 0.118 DBMET00104 0.182 0.049 DBMET00105 0.274 0.024 DBMET01676 0.248 0.029 DBMET00252 0.125 0.122 DBMET01211 | DBMET01676 | |
| 0.03 | 0.045 | 0.231 | Dopamine D2 agonist | 0.043 0.032 DBMET00104 0.231 0.005 DBMET00106 0.046 0.03 DBMET01211 | DBMET00106 | |
| 0.05 | 0.066 | 0.18 | 5 Hydroxytryptamine 1B antagonist | 0.18 0.01 DBMET00106 | DBMET00106 | |
| 0.068 | 0.086 | 0.075 | Neuropeptide Y antagonist | 0.075 0.067 DBMET00103 | DBMET00103 | |
| 0.038 | 0.056 | 0.05 | Potassium channel (Inward rectifier) blocker | 0.05 0.034 DBMET00333 0.049 0.035 DBMET00106 0.05 0.034 DBMET01212 | DBMET01212 | |
| 0.034 | 0.053 | 0.072 | Opioid mu receptor agonist | 0.072 0.019 DBMET00103 | DBMET00103 | |
| 0.072 | 0.091 | 0.089 | Thioredoxin reductase inhibitor | 0.076 0.075 DBMET00333 0.089 0.042 DBMET01676 0.085 0.05 DBMET00252 0.076 0.075 DBMET01212 | DBMET01676 | |
| 0.012 | 0.032 | 0.016 | Antibiotic Tetracycline-like | 0.016 0.008 DBMET00103 0.016 0.008 DBMET00105 | DBMET00105 | |
| 0.122 | 0.143 | 0.204 | Interleukin 6 antagonist | 0.188 0.049 DBMET00104 0.151 0.088 DBMET00105 0.177 0.057 DBMET01676 0.159 0.077 DBMET00252 0.204 0.038 DBMET01211 | DBMET01211 | |
| 0.174 | 0.197 | 0.387 | Transcription factor NF kappa B inhibitor | 0.248 0.129 DBMET00103 0.188 0.181 DBMET00104 0.387 0.066 DBMET00105 0.323 0.085 DBMET01676 0.272 0.112 DBMET00252 | DBMET00105 | |
| 0.146 | 0.17 | 0.368 | Interleukin agonist | 0.245 0.083 DBMET00103 0.276 0.061 DBMET00104 0.314 0.041 DBMET00105 0.18 0.139 DBMET00106 0.368 0.025 DBMET01676 0.339 0.032 DBMET00252 0.29 0.053 DBMET01211 | DBMET01676 | |
| 0.044 | 0.07 | 0.146 | 5 Hydroxytryptamine 2A agonist | 0.085 0.023 DBMET00333 0.088 0.021 DBMET00103 0.146 0.005 DBMET00106 0.085 0.023 DBMET01212 | DBMET00106 | |
| 0.079 | 0.106 | 0.097 | Alpha 2d adrenoreceptor antagonist | 0.097 0.054 DBMET00333 0.092 0.066 DBMET00106 0.097 0.054 DBMET01212 | DBMET01212 | |
| 0.009 | 0.036 | 0.02 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.02 0.013 DBMET00103 | DBMET00103 | |
| 0.04 | 0.068 | 0.099 | 5 Hydroxytryptamine 6 antagonist | 0.097 0.016 DBMET00103 0.099 0.015 DBMET00106 | DBMET00106 | |
| 0.022 | 0.05 | 0.051 | ATP citrate lysase inhibitor | 0.03 0.025 DBMET00333 0.029 0.028 DBMET00103 0.051 0.007 DBMET01676 0.039 0.013 DBMET00252 0.034 0.019 DBMET01211 0.03 0.025 DBMET01212 | DBMET01676 | |
| 0.091 | 0.12 | 0.173 | Interleukin 8 antagonist | 0.14 0.041 DBMET00333 0.164 0.026 DBMET00103 0.173 0.022 DBMET01676 0.132 0.048 DBMET00252 0.111 0.074 DBMET01211 0.14 0.041 DBMET01212 | DBMET01676 | |
| 0.037 | 0.066 | 0.075 | H+/K+-transporting ATPase inhibitor | 0.071 0.017 DBMET00333 0.05 0.037 DBMET00106 0.075 0.015 DBMET01676 0.067 0.019 DBMET00252 0.071 0.017 DBMET01212 | DBMET01676 | |
| 0.038 | 0.068 | 0.069 | Dopamine beta hydroxylase inhibitor | 0.056 0.02 DBMET00333 0.063 0.012 DBMET01676 0.069 0.009 DBMET00252 0.053 0.024 DBMET01211 0.056 0.02 DBMET01212 | DBMET00252 | |
| 0.111 | 0.142 | 0.31 | Dual specificity phosphatase 3 inhibitor | 0.131 0.114 DBMET00333 0.31 0.027 DBMET01676 0.272 0.034 DBMET00252 0.131 0.114 DBMET01212 | DBMET01676 | |
| 0.178 | 0.208 | 0.484 | Antithrombotic | 0.313 0.08 DBMET00103 0.217 0.157 DBMET00104 0.484 0.031 DBMET00105 0.343 0.067 DBMET01676 0.307 0.083 DBMET00252 | DBMET00105 | |
| 0.087 | 0.118 | 0.128 | Calcium channel N-type blocker | 0.128 0.054 DBMET00106 | DBMET00106 | |
| 0.055 | 0.086 | 0.064 | Calcium channel P-type blocker | 0.064 0.042 DBMET00103 0.063 0.047 DBMET00106 | DBMET00103 | |
| 0.018 | 0.051 | 0.068 | Prostaglandin D2 agonist | 0.059 0.005 DBMET00104 0.068 0.004 DBMET01676 0.067 0.004 DBMET00252 0.065 0.005 DBMET01211 | DBMET01676 | |
| 0.019 | 0.052 | 0.039 | Progesterone antagonist | 0.034 0.026 DBMET00333 0.037 0.024 DBMET01676 0.039 0.023 DBMET00252 0.031 0.028 DBMET01211 0.034 0.026 DBMET01212 | DBMET00252 | |
| 0.014 | 0.047 | 0.024 | Dopamine D1 agonist | 0.024 0.013 DBMET00103 | DBMET00103 | |
| 0.028 | 0.062 | 0.138 | Oleamide hydrolase inhibitor | 0.136 0.005 DBMET00333 0.048 0.029 DBMET00106 0.049 0.028 DBMET01676 0.04 0.037 DBMET00252 0.138 0.005 DBMET01211 0.136 0.005 DBMET01212 | DBMET01211 | |
| 0.019 | 0.054 | 0.028 | Thrombin receptor antagonist | 0.027 0.022 DBMET01676 0.028 0.02 DBMET00252 | DBMET00252 | |
| 0.026 | 0.062 | 0.048 | Acetylcholine M1 receptor agonist | 0.048 0.027 DBMET00103 0.045 0.029 DBMET00106 | DBMET00103 | |
| 0.052 | 0.088 | 0.064 | Kallikrein 7 inhibitor | 0.064 0.042 DBMET00333 0.064 0.042 DBMET01212 | DBMET01212 | |
| 0.081 | 0.119 | 0.339 | Amylase inhibitor | 0.102 0.095 DBMET00333 0.123 0.079 DBMET00103 0.294 0.019 DBMET00105 0.339 0.014 DBMET01676 0.287 0.02 DBMET00252 0.102 0.095 DBMET01212 | DBMET01676 | |
| 0.037 | 0.076 | 0.095 | Acetylcholine M2 receptor antagonist | 0.095 0.023 DBMET00104 0.093 0.023 DBMET00106 0.062 0.043 DBMET01211 | DBMET00104 | |
| 0.006 | 0.046 | 0.043 | Calcium-dependent phospholipase A2 inhibitor | 0.043 0.004 DBMET01676 0.029 0.004 DBMET00252 | DBMET01676 | |
| 0.094 | 0.134 | 0.19 | Cyclooxygenase inhibitor | 0.119 0.101 DBMET00333 0.184 0.048 DBMET01676 0.19 0.046 DBMET00252 0.119 0.101 DBMET01212 | DBMET00252 | |
| 0.017 | 0.057 | 0.043 | Sodium/glucose cotransporter inhibitor | 0.026 0.016 DBMET00103 0.043 0.006 DBMET00105 | DBMET00105 | |
| 0.022 | 0.063 | 0.059 | Estradiol 17 beta-dehydrogenase inhibitor | 0.04 0.031 DBMET01676 0.059 0.02 DBMET00252 | DBMET00252 | |
| 0.154 | 0.196 | 0.372 | DNA synthesis inhibitor | 0.204 0.118 DBMET00333 0.227 0.087 DBMET00103 0.273 0.054 DBMET00105 0.372 0.026 DBMET01676 0.333 0.034 DBMET00252 0.187 0.143 DBMET01211 0.204 0.118 DBMET01212 | DBMET01676 | |
| 0.056 | 0.1 | 0.198 | Macrophage migration inhibitory factor inhibitor | 0.101 0.034 DBMET00333 0.19 0.009 DBMET01676 0.198 0.008 DBMET00252 0.101 0.034 DBMET01212 | DBMET00252 | |
| 0.035 | 0.081 | 0.149 | HIV-1 integrase (Strand Transfer) inhibitor | 0.149 0.013 DBMET01676 0.118 0.017 DBMET00252 | DBMET01676 | |
| 0.014 | 0.06 | 0.045 | Sodium/glucose cotransporter 2 inhibitor | 0.026 0.019 DBMET00103 0.045 0.007 DBMET00105 | DBMET00105 | |
| 0.069 | 0.116 | 0.139 | Thioredoxin inhibitor | 0.085 0.071 DBMET00105 0.139 0.021 DBMET01676 0.126 0.027 DBMET00252 | DBMET01676 | |
| 0.011 | 0.059 | 0.027 | Squalene synthetase inhibitor | 0.027 0.026 DBMET00105 | DBMET00105 | |
| 0.075 | 0.123 | 0.162 | AMP-activated protein kinase stimulant | 0.141 0.034 DBMET00103 0.162 0.021 DBMET00105 0.098 0.073 DBMET00106 0.097 0.074 DBMET01676 0.108 0.061 DBMET00252 | DBMET00105 | |
| 0.109 | 0.159 | 0.133 | Death-associated protein kinase 1 inhibitor | 0.133 0.074 DBMET00333 0.119 0.117 DBMET01676 0.133 0.074 DBMET01212 | DBMET01212 | |
| 0.025 | 0.075 | 0.147 | Thromboxane A2 antagonist | 0.048 0.038 DBMET00333 0.147 0.004 DBMET01676 0.119 0.005 DBMET00252 0.048 0.038 DBMET01211 0.048 0.038 DBMET01212 | DBMET01676 | |
| 0.018 | 0.07 | 0.056 | Farnesoid X receptor agonist | 0.041 0.022 DBMET00103 0.042 0.021 DBMET01676 0.056 0.012 DBMET00252 | DBMET00252 | |
| 0.028 | 0.08 | 0.156 | Thromboxane antagonist | 0.052 0.04 DBMET00333 0.156 0.004 DBMET01676 0.136 0.005 DBMET00252 0.051 0.041 DBMET01211 0.052 0.04 DBMET01212 | DBMET01676 | |
| 0.038 | 0.091 | 0.174 | Sphingosine 1-phosphate receptor 3 antagonist | 0.07 0.025 DBMET00333 0.126 0.005 DBMET01676 0.174 0.004 DBMET00252 0.074 0.022 DBMET01211 0.07 0.025 DBMET01212 | DBMET00252 | |
| 0.022 | 0.076 | 0.053 | Glycine transporter inhibitor | 0.053 0.029 DBMET00103 | DBMET00103 | |
| 0.053 | 0.108 | 0.201 | MAO B inhibitor | 0.201 0.024 DBMET00333 0.146 0.039 DBMET00106 0.201 0.024 DBMET01212 | DBMET01212 | |
| 0.027 | 0.082 | 0.072 | Phenylethanolamine N methyltransferase inhibitor | 0.072 0.005 DBMET00103 0.048 0.017 DBMET00106 | DBMET00103 | |
| 0.081 | 0.136 | 0.15 | Cyclooxygenase 2 inhibitor | 0.145 0.058 DBMET01676 0.15 0.054 DBMET00252 | DBMET00252 | |
| 0.034 | 0.09 | 0.057 | Phosphodiesterase II inhibitor | 0.057 0.036 DBMET00103 0.054 0.04 DBMET00104 | DBMET00103 | |
| 0.022 | 0.078 | 0.047 | Opioid kappa receptor agonist | 0.047 0.026 DBMET00103 | DBMET00103 | |
| 0.151 | 0.208 | 0.295 | Nitric-oxide synthase stimulant | 0.204 0.083 DBMET00333 0.221 0.059 DBMET00103 0.166 0.163 DBMET00104 0.277 0.018 DBMET01676 0.295 0.013 DBMET00252 0.223 0.056 DBMET01211 0.204 0.083 DBMET01212 | DBMET00252 | |
| 0.079 | 0.136 | 0.139 | Nav1.5 sodium channel blocker | 0.132 0.041 DBMET00103 0.137 0.036 DBMET00104 0.1 0.084 DBMET00106 0.139 0.034 DBMET01211 | DBMET01211 | |
| 0.063 | 0.12 | 0.18 | Sphingomyelinase inhibitor | 0.086 0.078 DBMET00103 0.153 0.023 DBMET00104 0.097 0.063 DBMET00106 0.18 0.014 DBMET01211 | DBMET01211 | |
| 0.101 | 0.158 | 0.227 | Arachidonic acid antagonist | 0.181 0.052 DBMET00103 0.227 0.013 DBMET01676 0.219 0.018 DBMET00252 | DBMET01676 | |
| 0.036 | 0.093 | 0.103 | Purinergic P2 antagonist | 0.078 0.033 DBMET00333 0.079 0.033 DBMET01676 0.103 0.02 DBMET00252 0.078 0.033 DBMET01212 | DBMET00252 | |
| 0.029 | 0.087 | 0.05 | Phosphodiesterase 2A inhibitor | 0.05 0.034 DBMET00103 0.047 0.039 DBMET00104 | DBMET00103 | |
| 0.022 | 0.08 | 0.127 | Dopamine D5 agonist | 0.127 0.003 DBMET00103 | DBMET00103 | |
| 0.176 | 0.235 | 0.461 | Toll-Like receptor 7 agonist | 0.234 0.163 DBMET00103 0.461 0.04 DBMET00104 0.216 0.182 DBMET01676 0.236 0.161 DBMET00252 0.42 0.052 DBMET01211 | DBMET00104 | |
| 0.106 | 0.165 | 0.293 | Platelet adhesion inhibitor | 0.191 0.076 DBMET00103 0.188 0.077 DBMET00104 0.293 0.036 DBMET00105 0.216 0.063 DBMET01676 0.226 0.058 DBMET00252 | DBMET00105 | |
| 0.032 | 0.092 | 0.059 | 5 Hydroxytryptamine 3 antagonist | 0.052 0.045 DBMET00103 0.059 0.036 DBMET00106 | DBMET00106 | |
| 0.052 | 0.113 | 0.145 | Glycine receptor agonist | 0.145 0.007 DBMET00103 0.109 0.016 DBMET01676 0.116 0.014 DBMET00252 | DBMET00103 | |
| 0.052 | 0.114 | 0.18 | Adrenaline agonist | 0.091 0.045 DBMET00103 0.18 0.009 DBMET00104 0.078 0.061 DBMET00106 0.152 0.014 DBMET01211 | DBMET00104 | |
| 0.088 | 0.151 | 0.141 | Transcription factor STAT6 inhibitor | 0.134 0.039 DBMET00333 0.128 0.047 DBMET01676 0.141 0.031 DBMET00252 0.124 0.053 DBMET01211 0.134 0.039 DBMET01212 | DBMET00252 | |
| 0.029 | 0.093 | 0.058 | Acetylcholine muscarinic agonist | 0.058 0.035 DBMET00103 0.051 0.042 DBMET00106 | DBMET00103 | |
| 0.117 | 0.181 | 0.199 | ATPase inhibitor | 0.174 0.065 DBMET00103 0.199 0.038 DBMET00105 0.142 0.115 DBMET01676 0.169 0.072 DBMET00252 | DBMET00105 | |
| 0.142 | 0.206 | 0.159 | ErbB-1 antagonist | 0.159 0.158 DBMET00106 | DBMET00106 | |
| 0.051 | 0.116 | 0.066 | Prolactin release inhibitor | 0.066 0.03 DBMET00106 | DBMET00106 | |
| 0.017 | 0.083 | 0.03 | MAP3K8 inhibitor | 0.03 0.017 DBMET00103 | DBMET00103 | |
| 0.099 | 0.165 | 0.217 | NOS3 expression enhancer | 0.134 0.091 DBMET00333 0.217 0.035 DBMET00105 0.185 0.048 DBMET01676 0.179 0.05 DBMET00252 0.134 0.091 DBMET01211 0.134 0.091 DBMET01212 | DBMET00105 | |
| 0.007 | 0.073 | 0.04 | Thyroid hormone alpha antagonist | 0.04 0.004 DBMET01676 0.035 0.005 DBMET00252 | DBMET01676 | |
| 0.043 | 0.109 | 0.065 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.065 0.034 DBMET00333 0.065 0.034 DBMET01212 | DBMET01212 | |
| 0.01 | 0.077 | 0.035 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.035 0.013 DBMET00103 | DBMET00103 | |
| 0.004 | 0.071 | 0.066 | Prostaglandin EP4 agonist | 0.036 0.006 DBMET00104 0.036 0.006 DBMET01676 0.043 0.005 DBMET00252 0.066 0.004 DBMET01211 | DBMET01211 | |
| 0.028 | 0.095 | 0.074 | CC chemokine 4 receptor antagonist | 0.044 0.039 DBMET00333 0.045 0.036 DBMET00103 0.074 0.009 DBMET00106 0.044 0.039 DBMET01212 | DBMET00106 | |
| 0.027 | 0.095 | 0.051 | Vanilloid 3 antagonist | 0.047 0.011 DBMET01676 0.051 0.008 DBMET00252 | DBMET00252 | |
| 0.065 | 0.133 | 0.111 | D-Ala-D-Ala ligase inhibitor | 0.095 0.035 DBMET00333 0.087 0.051 DBMET00103 0.111 0.019 DBMET01676 0.097 0.033 DBMET00252 0.095 0.035 DBMET01212 | DBMET01676 | |
| 0.056 | 0.126 | 0.184 | Butyrylcholinesterase inhibitor | 0.184 0.024 DBMET00333 0.098 0.063 DBMET00106 0.086 0.074 DBMET01211 0.184 0.024 DBMET01212 | DBMET01212 | |
| 0.058 | 0.129 | 0.105 | Mediator release inhibitor | 0.099 0.072 DBMET00104 0.105 0.064 DBMET00105 0.097 0.074 DBMET01676 | DBMET00105 | |
| 0.032 | 0.105 | 0.076 | Nicotinic receptor alpha7 subunit antagonist | 0.076 0.018 DBMET00333 0.049 0.047 DBMET00103 0.054 0.037 DBMET00106 0.076 0.018 DBMET01212 | DBMET01212 | |
| 0.07 | 0.143 | 0.15 | Beta glucuronidase inhibitor | 0.096 0.076 DBMET00333 0.102 0.067 DBMET00103 0.15 0.025 DBMET00105 0.098 0.072 DBMET01676 0.097 0.075 DBMET00252 0.096 0.076 DBMET01212 | DBMET00105 | |
| 0.173 | 0.246 | 0.515 | GABA C receptor rho-3 antagonist | 0.329 0.097 DBMET00333 0.515 0.022 DBMET00103 0.261 0.145 DBMET01676 0.228 0.175 DBMET00252 0.215 0.19 DBMET01211 0.329 0.097 DBMET01212 | DBMET00103 | |
| 0.047 | 0.12 | 0.134 | Acetylcholine nicotinic antagonist | 0.111 0.033 DBMET00333 0.077 0.058 DBMET00103 0.134 0.025 DBMET00106 0.111 0.033 DBMET01212 | DBMET00106 | |
| 0.103 | 0.176 | 0.302 | Dual specificity phosphatase inhibitor | 0.302 0.028 DBMET01676 0.278 0.032 DBMET00252 | DBMET01676 | |
| 0.169 | 0.245 | 0.455 | Toll-Like receptor agonist | 0.226 0.172 DBMET00103 0.455 0.042 DBMET00104 0.223 0.176 DBMET01676 0.241 0.157 DBMET00252 0.416 0.054 DBMET01211 | DBMET00104 | |
| 0.103 | 0.179 | 0.221 | Melanin inhibitor | 0.146 0.087 DBMET00103 0.141 0.094 DBMET00105 0.221 0.034 DBMET01676 0.209 0.037 DBMET00252 | DBMET01676 | |
| 0.112 | 0.189 | 0.311 | Lipocortins synthesis antagonist | 0.311 0.019 DBMET01676 0.281 0.025 DBMET00252 | DBMET01676 | |
| 0.033 | 0.114 | 0.061 | Sphingosine kinase 2 inhibitor | 0.061 0.03 DBMET00103 | DBMET00103 | |
| 0.016 | 0.098 | 0.051 | HMG CoA reductase inhibitor | 0.051 0.007 DBMET01676 0.046 0.01 DBMET00252 | DBMET01676 | |
| 0.013 | 0.097 | 0.056 | Glutamate (mGluR2) antagonist | 0.056 0.007 DBMET00333 0.036 0.014 DBMET01676 0.031 0.019 DBMET00252 0.042 0.011 DBMET01211 0.056 0.007 DBMET01212 | DBMET01212 | |
| 0.052 | 0.137 | 0.145 | Inducible nitric-oxide synthase inhibitor | 0.145 0.017 DBMET00103 0.074 0.073 DBMET00104 0.087 0.051 DBMET01676 0.109 0.03 DBMET00252 | DBMET00103 | |
| 0.023 | 0.108 | 0.055 | Glutamate (mGluR8) antagonist | 0.054 0.007 DBMET01676 0.055 0.007 DBMET00252 | DBMET00252 | |
| 0.018 | 0.102 | 0.071 | Glutamate (mGluR group II) antagonist | 0.071 0.008 DBMET00333 0.066 0.009 DBMET01676 0.06 0.011 DBMET00252 0.057 0.012 DBMET01211 0.071 0.008 DBMET01212 | DBMET01212 | |
| 0.043 | 0.129 | 0.063 | Lipocortins synthesis agonist | 0.061 0.034 DBMET00105 0.063 0.031 DBMET01676 0.061 0.035 DBMET00252 | DBMET01676 | |
| 0.027 | 0.114 | 0.058 | Prolyl endopeptidase inhibitor | 0.056 0.028 DBMET01676 0.058 0.026 DBMET00252 | DBMET00252 | |
| 0.097 | 0.184 | 0.305 | Nitric oxide antagonist | 0.305 0.039 DBMET00105 0.154 0.091 DBMET01676 0.148 0.096 DBMET00252 | DBMET00105 | |
| 0.029 | 0.118 | 0.066 | Alpha-mannosidase inhibitor | 0.055 0.035 DBMET00103 0.062 0.025 DBMET00105 0.066 0.02 DBMET01676 0.06 0.026 DBMET00252 | DBMET01676 | |
| 0.106 | 0.195 | 0.448 | Aldehyde oxidase inhibitor | 0.448 0.04 DBMET00103 0.232 0.09 DBMET01676 0.185 0.113 DBMET00252 | DBMET00103 | |
| 0.014 | 0.103 | 0.035 | Opioid delta receptor agonist | 0.035 0.024 DBMET00103 | DBMET00103 | |
| 0.04 | 0.129 | 0.06 | Adenine nucleotide translocase inhibitor | 0.06 0.028 DBMET00105 0.055 0.039 DBMET01676 | DBMET00105 | |
| 0.165 | 0.255 | 0.53 | Histamine release inhibitor | 0.223 0.178 DBMET00333 0.412 0.069 DBMET00105 0.226 0.175 DBMET00106 0.53 0.02 DBMET01676 0.488 0.033 DBMET00252 0.223 0.178 DBMET01212 | DBMET01676 | |
| 0.096 | 0.186 | 0.123 | Neuropeptide Y1 antagonist | 0.123 0.116 DBMET00103 0.123 0.116 DBMET00106 | DBMET00106 | |
| 0.097 | 0.187 | 0.281 | DNA methyltransferase I inhibitor | 0.183 0.078 DBMET00105 0.281 0.034 DBMET01676 0.263 0.041 DBMET00252 | DBMET01676 | |
| 0.022 | 0.113 | 0.037 | Acid-sensing ion channel blocker | 0.037 0.035 DBMET00106 | DBMET00106 | |
| 0.032 | 0.124 | 0.144 | Leukotriene antagonist | 0.144 0.011 DBMET01676 0.14 0.011 DBMET00252 0.069 0.041 DBMET01211 | DBMET01676 | |
| 0.033 | 0.126 | 0.103 | HIV-1 integrase (3'-Processing) inhibitor | 0.103 0.025 DBMET01676 0.09 0.03 DBMET00252 | DBMET01676 | |
| 0.011 | 0.104 | 0.036 | Protein 30S ribosomal subunit inhibitor | 0.036 0.011 DBMET00105 | DBMET00105 | |
| 0.041 | 0.135 | 0.074 | Calcium antagonist | 0.074 0.069 DBMET00106 | DBMET00106 | |
| 0.02 | 0.115 | 0.042 | Liver X receptor alpha agonist | 0.042 0.028 DBMET01211 | DBMET01211 | |
| 0.154 | 0.249 | 0.372 | Immunosuppressant | 0.289 0.122 DBMET00104 0.372 0.075 DBMET00105 0.356 0.083 DBMET01676 0.341 0.092 DBMET00252 0.256 0.143 DBMET01211 | DBMET00105 | |
| 0.069 | 0.164 | 0.159 | Glutamate (mGluR7) agonist | 0.106 0.048 DBMET00106 0.159 0.009 DBMET01676 0.143 0.014 DBMET00252 0.089 0.085 DBMET01211 | DBMET01676 | |
| 0.018 | 0.114 | 0.15 | Glutamate (mGluR3) antagonist | 0.116 0.004 DBMET01676 0.15 0.004 DBMET00252 | DBMET00252 | |
| 0.031 | 0.129 | 0.111 | Neuronal nicotinic receptor antagonist | 0.099 0.025 DBMET00333 0.058 0.056 DBMET00103 0.111 0.02 DBMET00106 0.099 0.025 DBMET01212 | DBMET00106 | |
| 0.145 | 0.243 | 0.203 | 5 Hydroxytryptamine 3E antagonist | 0.198 0.066 DBMET00333 0.203 0.058 DBMET00103 0.17 0.136 DBMET00106 0.198 0.066 DBMET01212 | DBMET00103 | |
| 0.044 | 0.143 | 0.108 | Ca(v)2.2 blocker | 0.108 0.044 DBMET00106 | DBMET00106 | |
| 0.009 | 0.108 | 0.048 | Leukotriene D4 antagonist | 0.048 0.01 DBMET01676 0.047 0.011 DBMET00252 | DBMET01676 | |
| 0.008 | 0.107 | 0.061 | 5-Alpha-reductase 2 inhibitor | 0.061 0.006 DBMET01676 0.041 0.008 DBMET00252 | DBMET01676 | |
| 0.084 | 0.184 | 0.342 | Phospholipase A2 inhibitor | 0.178 0.055 DBMET00333 0.342 0.009 DBMET01676 0.322 0.01 DBMET00252 0.186 0.05 DBMET01211 0.178 0.055 DBMET01212 | DBMET01676 | |
| 0.062 | 0.163 | 0.126 | Hematopoietic | 0.126 0.02 DBMET01676 0.113 0.025 DBMET00252 | DBMET01676 | |
| 0.017 | 0.119 | 0.065 | RNA-directed RNA polymerase inhibitor | 0.065 0.009 DBMET01676 0.057 0.01 DBMET00252 | DBMET01676 | |
| 0.064 | 0.168 | 0.138 | Multidrug resistance-associated protein 1 inhibitor | 0.109 0.063 DBMET00105 0.101 0.076 DBMET00106 0.138 0.032 DBMET00252 | DBMET00252 | |
| 0.035 | 0.139 | 0.081 | 5 Hydroxytryptamine 3 agonist | 0.081 0.026 DBMET00103 | DBMET00103 | |
| 0.058 | 0.163 | 0.13 | Bile acid receptor antagonist | 0.088 0.078 DBMET00103 0.13 0.013 DBMET01676 0.117 0.023 DBMET00252 | DBMET01676 | |
| 0.038 | 0.144 | 0.074 | Aryl hydrocarbon receptor antagonist | 0.074 0.033 DBMET00333 0.074 0.033 DBMET01212 | DBMET01212 | |
| 0.005 | 0.112 | 0.066 | Purinergic P2T antagonist | 0.066 0.008 DBMET01676 0.066 0.008 DBMET00252 | DBMET00252 | |
| 0.143 | 0.251 | 0.325 | Vasodilator, coronary | 0.325 0.069 DBMET00105 0.301 0.086 DBMET01676 0.253 0.131 DBMET00252 | DBMET00105 | |
| 0.011 | 0.118 | 0.04 | 5 Hydroxytryptamine 1F agonist | 0.04 0.007 DBMET00106 | DBMET00106 | |
| 0.003 | 0.11 | 0.015 | Thromboxane agonist | 0.015 0.005 DBMET01676 0.014 0.005 DBMET00252 0.01 0.009 DBMET01211 | DBMET01676 | |
| 0.004 | 0.113 | 0.041 | Prostaglandin H2 antagonist | 0.041 0.005 DBMET01676 0.036 0.008 DBMET00252 | DBMET01676 | |
| 0.134 | 0.243 | 0.288 | RNA-directed DNA polymerase inhibitor | 0.288 0.034 DBMET00103 0.202 0.097 DBMET01676 0.2 0.1 DBMET00252 | DBMET00103 | |
| 0.031 | 0.141 | 0.05 | Autotaxin inhibitor | 0.05 0.042 DBMET01676 0.05 0.04 DBMET00252 | DBMET00252 | |
| 0.039 | 0.152 | 0.063 | Interferon inducer | 0.063 0.046 DBMET00103 | DBMET00103 | |
| 0.025 | 0.138 | 0.078 | GABA B receptor antagonist | 0.039 0.038 DBMET00333 0.055 0.015 DBMET00103 0.041 0.034 DBMET00106 0.078 0.007 DBMET01676 0.066 0.01 DBMET00252 0.039 0.038 DBMET01212 | DBMET01676 | |
| 0.008 | 0.123 | 0.157 | Glutamate (mGluR1a) agonist | 0.157 0.003 DBMET01676 0.1 0.004 DBMET00252 | DBMET01676 | |
| 0.018 | 0.134 | 0.089 | Glutamate (mGluR3) agonist | 0.089 0.002 DBMET01676 0.085 0.003 DBMET00252 | DBMET01676 | |
| 0.093 | 0.209 | 0.265 | DNA methylase inhibitor | 0.212 0.071 DBMET00105 0.265 0.04 DBMET01676 0.243 0.052 DBMET00252 | DBMET01676 | |
| 0.013 | 0.129 | 0.035 | Histone deacetylase 8 inhibitor | 0.035 0.034 DBMET00333 0.035 0.034 DBMET01212 | DBMET01212 | |
| 0.019 | 0.136 | 0.12 | Sphingosine 1-phosphate receptor agonist | 0.116 0.005 DBMET01676 0.12 0.005 DBMET00252 | DBMET00252 | |
| 0.007 | 0.123 | 0.033 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.02 0.017 DBMET01676 0.033 0.01 DBMET00252 | DBMET00252 | |
| 0.009 | 0.126 | 0.015 | CC chemokine 10 receptor antagonist | 0.015 0.012 DBMET00333 0.015 0.012 DBMET01212 | DBMET01212 | |
| 0.005 | 0.122 | 0.025 | 5-Alpha-reductase 1 inhibitor | 0.025 0.009 DBMET01676 0.015 0.013 DBMET00252 | DBMET01676 | |
| 0.025 | 0.143 | 0.081 | TRPA1 antagonist | 0.081 0.025 DBMET00333 0.081 0.025 DBMET01212 | DBMET01212 | |
| 0.112 | 0.231 | 0.204 | Neurotensin receptor agonist | 0.164 0.072 DBMET00333 0.151 0.098 DBMET00103 0.204 0.033 DBMET01676 0.185 0.045 DBMET00252 0.164 0.072 DBMET01212 | DBMET01676 | |
| 0.012 | 0.131 | 0.039 | Liver X receptor beta agonist | 0.039 0.016 DBMET01211 | DBMET01211 | |
| 0.031 | 0.151 | 0.124 | CD45 antagonist | 0.124 0.007 DBMET01676 0.108 0.008 DBMET00252 | DBMET01676 | |
| 0.018 | 0.138 | 0.224 | Prostaglandin EP2 antagonist | 0.077 0.028 DBMET00104 0.223 0.005 DBMET01676 0.224 0.005 DBMET00252 0.134 0.012 DBMET01211 | DBMET00252 | |
| 0.033 | 0.154 | 0.084 | Purinergic P2X1 antagonist | 0.07 0.032 DBMET00103 0.084 0.023 DBMET01676 0.073 0.029 DBMET00252 | DBMET01676 | |
| 0.042 | 0.164 | 0.082 | Acetylcholine agonist | 0.082 0.063 DBMET00103 0.076 0.072 DBMET00106 | DBMET00103 | |
| 0.011 | 0.134 | 0.025 | Calcium-sensing receptor agonist | 0.025 0.021 DBMET01676 0.024 0.022 DBMET00252 | DBMET01676 | |
| 0.11 | 0.235 | 0.163 | Death-associated protein kinase 2 inhibitor | 0.163 0.079 DBMET00103 | DBMET00103 | |
| 0.009 | 0.135 | 0.091 | 5-Alpha-reductase inhibitor | 0.091 0.011 DBMET01676 0.072 0.013 DBMET00252 | DBMET01676 | |
| 0.025 | 0.151 | 0.066 | Aldosterone antagonist | 0.065 0.016 DBMET01676 0.066 0.016 DBMET00252 | DBMET00252 | |
| 0.009 | 0.135 | 0.043 | Liver X receptor beta antagonist | 0.039 0.013 DBMET01676 0.043 0.011 DBMET01211 | DBMET01211 | |
| 0.015 | 0.142 | 0.057 | Factor XIIIa inhibitor | 0.057 0.013 DBMET01676 0.048 0.017 DBMET00252 | DBMET01676 | |
| 0.016 | 0.143 | 0.026 | Hedgehog signaling activator | 0.026 0.023 DBMET00103 | DBMET00103 | |
| 0.014 | 0.142 | 0.027 | Thymidine phosphorylase inhibitor | 0.027 0.016 DBMET00103 | DBMET00103 | |
| 0.014 | 0.143 | 0.075 | Phosphorylase inhibitor | 0.041 0.036 DBMET00105 0.051 0.03 DBMET01676 0.075 0.018 DBMET00252 0.041 0.036 DBMET01211 | DBMET00252 | |
| 0.043 | 0.172 | 0.068 | Beta 2 adrenoreceptor agonist | 0.068 0.024 DBMET00104 0.064 0.034 DBMET01211 | DBMET00104 | |
| 0.023 | 0.153 | 0.059 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.04 0.032 DBMET00103 0.057 0.009 DBMET01676 0.059 0.008 DBMET00252 | DBMET00252 | |
| 0.024 | 0.155 | 0.093 | Purinergic P2X4 antagonist | 0.093 0.005 DBMET00103 | DBMET00103 | |
| 0.009 | 0.141 | 0.043 | Prostaglandin F2 alpha agonist | 0.043 0.005 DBMET01676 0.038 0.006 DBMET00252 | DBMET01676 | |
| 0.088 | 0.221 | 0.205 | Adenylate cyclase stimulant | 0.205 0.011 DBMET00103 0.132 0.097 DBMET00104 0.159 0.048 DBMET01676 0.15 0.062 DBMET00252 | DBMET00103 | |
| 0.008 | 0.141 | 0.034 | AMPA 3 receptor antagonist | 0.034 0.017 DBMET01676 | DBMET01676 | |
| 0.008 | 0.142 | 0.043 | HCV NS5B polymerase inhibitor | 0.043 0.012 DBMET01676 0.04 0.014 DBMET00252 | DBMET01676 | |
| 0.005 | 0.139 | 0.024 | Thromboxane A2 agonist | 0.024 0.004 DBMET01676 0.023 0.004 DBMET00252 | DBMET01676 | |
| 0.025 | 0.159 | 0.141 | Alpha 2 adrenoreceptor agonist | 0.141 0.007 DBMET00103 | DBMET00103 | |
| 0.017 | 0.152 | 0.062 | Mannosidase inhibitor | 0.046 0.03 DBMET00103 0.041 0.038 DBMET00104 0.047 0.029 DBMET00105 0.062 0.016 DBMET01676 0.055 0.021 DBMET00252 | DBMET01676 | |
| 0.02 | 0.157 | 0.067 | 5 Hydroxytryptamine 2B agonist | 0.067 0.007 DBMET00103 0.039 0.027 DBMET00106 | DBMET00103 | |
| 0.012 | 0.15 | 0.084 | Sphingosine 1-phosphate receptor 1 agonist | 0.08 0.006 DBMET01676 0.084 0.005 DBMET00252 | DBMET00252 | |
| 0.031 | 0.17 | 0.12 | Sphingosine 1-phosphate receptor 1 antagonist | 0.108 0.008 DBMET01676 0.12 0.006 DBMET00252 0.08 0.014 DBMET01211 | DBMET00252 | |
| 0.025 | 0.165 | 0.095 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.095 0.019 DBMET01676 0.087 0.021 DBMET00252 | DBMET01676 | |
| 0.012 | 0.152 | 0.029 | Integrin alpha2beta1 antagonist | 0.026 0.019 DBMET00103 0.029 0.013 DBMET01676 | DBMET01676 | |
| 0.007 | 0.148 | 0.072 | Purinergic P2Y12 antagonist | 0.072 0.005 DBMET01676 0.07 0.005 DBMET00252 | DBMET01676 | |
| 0.075 | 0.217 | 0.187 | Cell wall synthesis inhibitor | 0.122 0.097 DBMET00333 0.161 0.055 DBMET00103 0.113 0.11 DBMET00104 0.173 0.045 DBMET00105 0.187 0.036 DBMET01676 0.176 0.043 DBMET00252 0.186 0.036 DBMET01211 0.122 0.097 DBMET01212 | DBMET01676 | |
| 0.003 | 0.146 | 0.106 | G-protein-coupled receptor 120 agonist | 0.069 0.003 DBMET01676 0.106 0.003 DBMET00252 | DBMET00252 | |
| 0.026 | 0.169 | 0.35 | Catalase inhibitor | 0.086 0.044 DBMET00333 0.324 0.005 DBMET01676 0.35 0.005 DBMET00252 0.097 0.04 DBMET01211 0.086 0.044 DBMET01212 | DBMET00252 | |
| 0.022 | 0.165 | 0.172 | Carbamoyl phosphate synthetase inhibitor | 0.069 0.035 DBMET00103 0.172 0.009 DBMET01676 0.155 0.011 DBMET00252 | DBMET01676 | |
| 0.028 | 0.172 | 0.051 | Fatty acid synthase inhibitor | 0.051 0.05 DBMET01676 | DBMET01676 | |
| 0.062 | 0.207 | 0.164 | Cyclooxygenase 3 inhibitor | 0.157 0.043 DBMET00103 0.164 0.037 DBMET00105 0.124 0.073 DBMET01676 0.136 0.061 DBMET00252 0.137 0.06 DBMET01211 | DBMET00105 | |
| 0.019 | 0.164 | 0.052 | Poly(ADP-ribose) polymerase inhibitor | 0.052 0.022 DBMET00106 | DBMET00106 | |
| 0.004 | 0.151 | 0.042 | Arginase inhibitor | 0.033 0.029 DBMET00103 0.042 0.02 DBMET01676 0.042 0.02 DBMET00252 | DBMET00252 | |
| 0.01 | 0.157 | 0.044 | Carbonic anhydrase VII inhibitor | 0.044 0.036 DBMET00103 | DBMET00103 | |
| 0.005 | 0.152 | 0.028 | Dopamine autoreceptor agonist | 0.028 0.014 DBMET00106 | DBMET00106 | |
| 0.018 | 0.165 | 0.039 | AMPA 4 receptor antagonist | 0.037 0.032 DBMET00103 0.039 0.028 DBMET01676 | DBMET01676 | |
| 0.014 | 0.162 | 0.028 | Estrogen-related receptor gamma antagonist | 0.028 0.02 DBMET01676 0.027 0.025 DBMET00252 | DBMET01676 | |
| 0.033 | 0.181 | 0.083 | Ca(v)3.2 blocker | 0.083 0.013 DBMET00106 | DBMET00106 | |
| 0.009 | 0.157 | 0.04 | 5 Hydroxytryptamine 3B antagonist | 0.04 0.02 DBMET00106 | DBMET00106 | |
| 0.021 | 0.17 | 0.052 | GABA A receptor antagonist | 0.052 0.039 DBMET00103 | DBMET00103 | |
| 0.008 | 0.157 | 0.04 | Kainate receptor 2 antagonist | 0.04 0.022 DBMET00103 0.037 0.024 DBMET01676 | DBMET00103 | |
| 0.016 | 0.166 | 0.089 | 5 Hydroxytryptamine 2 agonist | 0.057 0.03 DBMET00333 0.07 0.019 DBMET00103 0.089 0.012 DBMET00106 0.057 0.03 DBMET01212 | DBMET00106 | |
| 0.028 | 0.178 | 0.064 | Sphingosine kinase inhibitor | 0.064 0.033 DBMET00103 | DBMET00103 | |
| 0.018 | 0.169 | 0.04 | Sphingosine kinase 1 inhibitor | 0.04 0.03 DBMET00103 | DBMET00103 | |
| 0.014 | 0.165 | 0.044 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.044 0.02 DBMET00106 | DBMET00106 | |
| 0.041 | 0.193 | 0.126 | Glutamate (mGluR6) antagonist | 0.077 0.028 DBMET00103 0.126 0.005 DBMET01676 0.125 0.005 DBMET00252 | DBMET01676 | |
| 0.048 | 0.201 | 0.126 | Anabolic | 0.104 0.058 DBMET00103 0.126 0.034 DBMET01676 0.116 0.044 DBMET00252 | DBMET01676 | |
| 0.047 | 0.2 | 0.078 | Falcipain inhibitor | 0.078 0.077 DBMET00333 0.078 0.077 DBMET01212 | DBMET01212 | |
| 0.02 | 0.174 | 0.056 | GABA receptor antagonist | 0.056 0.035 DBMET00103 | DBMET00103 | |
| 0.052 | 0.207 | 0.114 | Transcription factor NF kappa B stimulant | 0.1 0.039 DBMET00105 0.114 0.028 DBMET01676 0.099 0.04 DBMET00252 | DBMET01676 | |
| 0.003 | 0.159 | 0.013 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.013 0.01 DBMET00252 | DBMET00252 | |
| 0.011 | 0.166 | 0.031 | 5 Hydroxytryptamine 6 agonist | 0.031 0.015 DBMET00103 0.027 0.024 DBMET00106 | DBMET00103 | |
| 0.011 | 0.167 | 0.034 | Peptide deformylase inhibitor | 0.029 0.023 DBMET01676 0.034 0.018 DBMET00252 | DBMET00252 | |
| 0.003 | 0.159 | 0.053 | Peroxisome proliferator-activated receptor alpha antagonist | 0.053 0.008 DBMET01676 0.034 0.01 DBMET00252 | DBMET01676 | |
| 0.004 | 0.162 | 0.019 | Cyclin T1 inhibitor | 0.019 0.011 DBMET00103 | DBMET00103 | |
| 0.008 | 0.166 | 0.068 | Prostaglandin EP4 antagonist | 0.043 0.01 DBMET01676 0.051 0.008 DBMET00252 0.068 0.006 DBMET01211 | DBMET01211 | |
| 0.207 | 0.366 | 0.346 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.32 0.187 DBMET00333 0.346 0.155 DBMET00103 0.326 0.179 DBMET01676 0.299 0.215 DBMET00252 0.266 0.262 DBMET01211 0.32 0.187 DBMET01212 | DBMET00103 | |
| 0.008 | 0.167 | 0.075 | Free fatty acid receptor 1 antagonist | 0.075 0.004 DBMET01676 0.071 0.004 DBMET00252 | DBMET01676 | |
| 0.022 | 0.182 | 0.054 | Kainate receptor agonist | 0.047 0.018 DBMET00103 0.054 0.01 DBMET01676 0.05 0.014 DBMET00252 | DBMET01676 | |
| 0.061 | 0.222 | 0.125 | NADPH oxidase inhibitor | 0.105 0.104 DBMET00333 0.125 0.077 DBMET01676 0.105 0.104 DBMET01212 | DBMET01676 | |
| 0.035 | 0.198 | 0.065 | Potassium channel large-conductance Ca-activated activator | 0.065 0.05 DBMET01676 | DBMET01676 | |
| 0.064 | 0.227 | 0.176 | Amyloid beta aggregation inhibitor | 0.176 0.091 DBMET00333 0.128 0.127 DBMET01676 0.15 0.108 DBMET00252 0.175 0.092 DBMET01211 0.176 0.091 DBMET01212 | DBMET01212 | |
| 0.074 | 0.24 | 0.237 | Mannose-6-phosphate isomerase inhibitor | 0.237 0.015 DBMET01676 0.188 0.038 DBMET00252 | DBMET01676 | |
| 0.108 | 0.274 | 0.272 | Thyroid hormone beta antagonist | 0.206 0.149 DBMET00333 0.233 0.13 DBMET00106 0.272 0.103 DBMET01676 0.221 0.137 DBMET00252 0.206 0.149 DBMET01212 | DBMET01676 | |
| 0.019 | 0.186 | 0.051 | Nicotinic receptor alpha4 subunit antagonist | 0.046 0.043 DBMET00333 0.051 0.03 DBMET00103 0.046 0.043 DBMET01212 | DBMET00103 | |
| 0.035 | 0.202 | 0.082 | Myeloperoxidase inhibitor | 0.082 0.063 DBMET00333 0.08 0.066 DBMET01676 0.082 0.063 DBMET01212 | DBMET01212 | |
| 0.029 | 0.197 | 0.054 | Glucosylceramidase inhibitor | 0.054 0.04 DBMET00103 | DBMET00103 | |
| 0.007 | 0.175 | 0.07 | Glucagon receptor antagonist | 0.063 0.007 DBMET01676 0.07 0.006 DBMET00252 0.061 0.008 DBMET01211 | DBMET00252 | |
| 0.019 | 0.19 | 0.12 | Prostaglandin-E synthase inhibitor | 0.07 0.048 DBMET00333 0.12 0.02 DBMET01676 0.108 0.023 DBMET00252 0.07 0.048 DBMET01212 | DBMET01676 | |
| 0.018 | 0.19 | 0.041 | Histamine H1 receptor agonist | 0.041 0.036 DBMET00103 | DBMET00103 | |
| 0.046 | 0.218 | 0.386 | Triose-phosphate isomerase inhibitor | 0.086 0.066 DBMET00103 0.386 0.004 DBMET01676 0.349 0.004 DBMET00252 | DBMET01676 | |
| 0.048 | 0.221 | 0.361 | GABA C receptor antagonist | 0.361 0.004 DBMET00103 0.118 0.054 DBMET01676 0.124 0.049 DBMET00252 | DBMET00103 | |
| 0.015 | 0.191 | 0.052 | Integrin alpha2 antagonist | 0.052 0.01 DBMET00103 0.051 0.011 DBMET01676 0.038 0.024 DBMET00252 | DBMET00103 | |
| 0.004 | 0.18 | 0.019 | Nicotinic acid receptor 1 antagonist | 0.017 0.012 DBMET01676 0.019 0.01 DBMET00252 | DBMET00252 | |
| 0.019 | 0.195 | 0.032 | HCV polyprotein inhibitor | 0.032 0.029 DBMET01676 | DBMET01676 | |
| 0.008 | 0.185 | 0.032 | Carnitine palmitoyltransferase inhibitor | 0.032 0.028 DBMET01676 0.032 0.026 DBMET00252 | DBMET00252 | |
| 0.025 | 0.202 | 0.046 | CXC chemokine 1 receptor antagonist | 0.046 0.045 DBMET01676 | DBMET01676 | |
| 0.024 | 0.203 | 0.06 | Alpha 1L adrenoreceptor agonist | 0.06 0.008 DBMET00103 | DBMET00103 | |
| 0.082 | 0.263 | 0.519 | Platelet antagonist | 0.263 0.067 DBMET00105 0.519 0.012 DBMET01676 0.486 0.015 DBMET00252 | DBMET01676 | |
| 0.042 | 0.223 | 0.46 | Ferrochelatase inhibitor | 0.125 0.05 DBMET00103 0.435 0.003 DBMET01676 0.46 0.003 DBMET00252 0.138 0.043 DBMET01211 | DBMET00252 | |
| 0.022 | 0.204 | 0.082 | Androgen agonist | 0.082 0.023 DBMET00103 | DBMET00103 | |
| 0.022 | 0.206 | 0.051 | Potassium channel (ATP-sensitive) activator | 0.051 0.028 DBMET00103 | DBMET00103 | |
| 0.043 | 0.226 | 0.13 | Glutathione S-transferase inhibitor | 0.13 0.018 DBMET01676 0.106 0.032 DBMET00252 | DBMET01676 | |
| 0.004 | 0.188 | 0.023 | Prostacyclin agonist | 0.023 0.007 DBMET01676 0.021 0.008 DBMET00252 | DBMET01676 | |
| 0.102 | 0.286 | 0.297 | Thyroid hormone antagonist | 0.203 0.16 DBMET00333 0.222 0.143 DBMET00106 0.297 0.095 DBMET01676 0.248 0.125 DBMET00252 0.203 0.16 DBMET01212 | DBMET01676 | |
| 0.078 | 0.262 | 0.165 | Vanilloid 1 agonist | 0.165 0.026 DBMET01676 0.155 0.034 DBMET00252 | DBMET01676 | |
| 0.024 | 0.21 | 0.053 | Potassium channel (Inward rectifier) activator | 0.053 0.029 DBMET00103 | DBMET00103 | |
| 0.044 | 0.23 | 0.14 | GABA receptor agonist | 0.103 0.073 DBMET00333 0.093 0.086 DBMET00106 0.14 0.042 DBMET01676 0.134 0.046 DBMET00252 0.103 0.073 DBMET01212 | DBMET01676 | |
| 0.021 | 0.208 | 0.109 | Leukotriene B4 antagonist | 0.109 0.009 DBMET01676 0.09 0.013 DBMET00252 | DBMET01676 | |
| 0.135 | 0.323 | 0.211 | Caspase 3 stimulant | 0.199 0.171 DBMET00105 0.211 0.154 DBMET01676 0.199 0.17 DBMET00252 | DBMET01676 | |
| 0.039 | 0.228 | 0.085 | Antineoplastic alkaloid | 0.085 0.06 DBMET00103 | DBMET00103 | |
| 0.048 | 0.237 | 0.218 | Caspase 3 inhibitor | 0.21 0.008 DBMET01676 0.218 0.007 DBMET00252 | DBMET00252 | |
| 0.039 | 0.228 | 0.108 | Prolactin inhibitor | 0.108 0.048 DBMET00103 0.099 0.057 DBMET01676 0.086 0.073 DBMET00252 | DBMET00103 | |
| 0.034 | 0.225 | 0.063 | Ryanodine receptor antagonist | 0.063 0.029 DBMET00103 | DBMET00103 | |
| 0.041 | 0.233 | 0.16 | UDP-glucose 4-epimerase inhibitor | 0.107 0.054 DBMET00103 0.1 0.061 DBMET00105 0.16 0.026 DBMET01676 0.142 0.032 DBMET00252 | DBMET01676 | |
| 0.005 | 0.198 | 0.05 | Sphingosine 1-phosphate receptor 3 agonist | 0.046 0.018 DBMET01676 0.05 0.016 DBMET00252 | DBMET00252 | |
| 0.048 | 0.244 | 0.17 | Bone formation stimulant | 0.17 0.046 DBMET01676 0.167 0.047 DBMET00252 | DBMET01676 | |
| 0.012 | 0.208 | 0.034 | Histone deacetylase 7 inhibitor | 0.034 0.029 DBMET01676 | DBMET01676 | |
| 0.023 | 0.221 | 0.325 | Glutamate decarboxylase inhibitor | 0.325 0.003 DBMET01676 0.288 0.004 DBMET00252 | DBMET01676 | |
| 0.061 | 0.259 | 0.219 | Protein kinase stimulant | 0.148 0.07 DBMET00103 0.219 0.035 DBMET01676 0.2 0.042 DBMET00252 | DBMET01676 | |
| 0.074 | 0.273 | 0.146 | DNA repair enzyme inhibitor | 0.143 0.038 DBMET00105 0.146 0.035 DBMET01676 0.14 0.042 DBMET00252 | DBMET01676 | |
| 0.029 | 0.228 | 0.179 | Potassium channel (Ca-activated) activator | 0.167 0.023 DBMET01676 0.179 0.019 DBMET00252 | DBMET00252 | |
| 0.025 | 0.225 | 0.134 | MAO A inhibitor | 0.134 0.046 DBMET00333 0.081 0.08 DBMET00106 0.134 0.046 DBMET01212 | DBMET01212 | |
| 0.055 | 0.255 | 0.346 | Aldehyde dehydrogenase inhibitor | 0.144 0.051 DBMET00333 0.346 0.008 DBMET01676 0.322 0.01 DBMET00252 0.144 0.051 DBMET01212 | DBMET01676 | |
| 0.041 | 0.243 | 0.096 | Potassium channel (Voltage-sensitive) activator | 0.096 0.058 DBMET00333 0.088 0.072 DBMET00252 0.096 0.058 DBMET01212 | DBMET01212 | |
| 0.066 | 0.27 | 0.126 | Sphingosine 1-phosphate receptor 4 antagonist | 0.106 0.105 DBMET00103 0.126 0.062 DBMET01676 0.114 0.086 DBMET00252 | DBMET01676 | |
| 0.095 | 0.3 | 0.197 | Thioredoxin glutathione reductase inhibitor | 0.197 0.175 DBMET01676 | DBMET01676 | |
| 0.009 | 0.214 | 0.098 | Peroxisome proliferator-activated receptor alpha agonist | 0.098 0.013 DBMET01676 0.093 0.014 DBMET00252 | DBMET01676 | |
| 0.026 | 0.234 | 0.089 | Potassium channel (Ca-activated) blocker | 0.089 0.013 DBMET00333 0.06 0.041 DBMET01211 0.089 0.013 DBMET01212 | DBMET01212 | |
| 0.005 | 0.212 | 0.026 | CXC chemokine 2 receptor antagonist | 0.024 0.022 DBMET01676 0.026 0.018 DBMET00252 | DBMET00252 | |
| 0.053 | 0.262 | 0.207 | Toll-Like receptor 2 antagonist | 0.118 0.08 DBMET00103 0.202 0.023 DBMET01676 0.207 0.02 DBMET00252 | DBMET00252 | |
| 0.006 | 0.215 | 0.074 | Peroxisome proliferator-activated receptor delta agonist | 0.074 0.008 DBMET01676 0.073 0.008 DBMET00252 | DBMET01676 | |
| 0.024 | 0.237 | 0.12 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.12 0.029 DBMET01676 0.09 0.043 DBMET00252 | DBMET01676 | |
| 0.034 | 0.248 | 0.068 | Exportin-1 inhibitor | 0.067 0.049 DBMET00103 0.068 0.048 DBMET01676 0.064 0.06 DBMET00252 0.064 0.06 DBMET01211 | DBMET01676 | |
| 0.008 | 0.222 | 0.03 | Caspase 8 inhibitor | 0.028 0.006 DBMET01676 0.03 0.005 DBMET00252 | DBMET00252 | |
| 0.132 | 0.349 | 0.375 | Interleukin 2 agonist | 0.197 0.194 DBMET00103 0.218 0.16 DBMET00104 0.352 0.045 DBMET00105 0.375 0.035 DBMET01676 0.342 0.049 DBMET00252 0.263 0.105 DBMET01211 | DBMET01676 | |
| 0.02 | 0.239 | 0.076 | Thromboxane synthase inhibitor | 0.053 0.041 DBMET00333 0.076 0.014 DBMET01676 0.066 0.021 DBMET00252 0.068 0.019 DBMET01211 0.053 0.041 DBMET01212 | DBMET01676 | |
| 0.109 | 0.33 | 0.22 | Nootropic | 0.22 0.134 DBMET00333 0.219 0.135 DBMET01211 0.22 0.134 DBMET01212 | DBMET01212 | |
| 0.014 | 0.238 | 0.057 | Retinoid X alpha receptor antagonist | 0.057 0.004 DBMET01676 0.053 0.005 DBMET00252 | DBMET01676 | |
| 0.037 | 0.261 | 0.516 | GABA C receptor agonist | 0.394 0.005 DBMET00103 0.516 0.004 DBMET01676 0.473 0.004 DBMET00252 | DBMET01676 | |
| 0.032 | 0.257 | 0.115 | Urease inhibitor | 0.115 0.05 DBMET01211 | DBMET01211 | |
| 0.099 | 0.325 | 0.184 | Transcription factor STAT3 inhibitor | 0.184 0.158 DBMET01676 0.181 0.162 DBMET00252 | DBMET01676 | |
| 0.085 | 0.312 | 0.251 | Phospholipase C inhibitor | 0.167 0.077 DBMET00103 0.251 0.025 DBMET01676 0.203 0.042 DBMET00252 | DBMET01676 | |
| 0.007 | 0.234 | 0.093 | Fumarate hydratase inhibitor | 0.093 0.006 DBMET01676 0.08 0.007 DBMET00252 | DBMET01676 | |
| 0.019 | 0.246 | 0.033 | Calcium-independent phospholipase A2 inhibitor | 0.033 0.029 DBMET01676 | DBMET01676 | |
| 0.009 | 0.237 | 0.066 | Alpha 1d adrenoreceptor agonist | 0.04 0.025 DBMET00103 0.066 0.009 DBMET01211 | DBMET01211 | |
| 0.02 | 0.248 | 0.102 | Glucose-6-phosphate isomerase inhibitor | 0.102 0.005 DBMET01676 0.095 0.005 DBMET00252 | DBMET01676 | |
| 0.068 | 0.297 | 0.294 | Hepatoprotectant | 0.294 0.031 DBMET00105 0.172 0.088 DBMET01676 0.163 0.097 DBMET00252 | DBMET00105 | |
| 0.042 | 0.272 | 0.116 | NADH dehydrogenase inhibitor | 0.116 0.031 DBMET00103 0.11 0.034 DBMET01676 0.101 0.043 DBMET00252 | DBMET00103 | |
| 0.005 | 0.235 | 0.053 | G protein-coupled receptor agonist | 0.04 0.024 DBMET01676 0.053 0.016 DBMET00252 | DBMET00252 | |
| 0.031 | 0.262 | 0.083 | Potassium channel activator | 0.083 0.071 DBMET00252 | DBMET00252 | |
| 0.013 | 0.244 | 0.049 | Carbonic anhydrase XIV inhibitor | 0.049 0.034 DBMET00103 | DBMET00103 | |
| 0.015 | 0.247 | 0.067 | Retinoid X receptor antagonist | 0.067 0.004 DBMET01676 0.063 0.005 DBMET00252 | DBMET01676 | |
| 0.024 | 0.257 | 0.099 | Cathepsin G inhibitor | 0.099 0.034 DBMET01676 0.077 0.046 DBMET00252 | DBMET01676 | |
| 0.06 | 0.293 | 0.128 | Heat shock protein 90 alpha antagonist | 0.128 0.115 DBMET00103 | DBMET00103 | |
| 0.016 | 0.249 | 0.092 | AICAR transformylase inhibitor | 0.078 0.008 DBMET01676 0.092 0.005 DBMET00252 | DBMET00252 | |
| 0.101 | 0.335 | 0.211 | Transcription factor STAT inhibitor | 0.194 0.147 DBMET01676 0.211 0.123 DBMET00252 | DBMET00252 | |
| 0.006 | 0.24 | 0.077 | Prostacyclin antagonist | 0.077 0.005 DBMET01676 0.077 0.005 DBMET00252 | DBMET00252 | |
| 0.024 | 0.263 | 0.056 | Dihydroorotate oxidase inhibitor | 0.054 0.04 DBMET00103 0.056 0.036 DBMET01676 | DBMET01676 | |
| 0.004 | 0.243 | 0.046 | Uridine phosphorylase inhibitor | 0.046 0.009 DBMET01676 0.043 0.011 DBMET00252 | DBMET01676 | |
| 0.017 | 0.256 | 0.237 | Aconitate hydratase inhibitor | 0.237 0.003 DBMET01676 0.208 0.003 DBMET00252 | DBMET01676 | |
| 0.021 | 0.261 | 0.058 | Glucose-6-phosphate translocase inhibitor | 0.058 0.025 DBMET00105 | DBMET00105 | |
| 0.112 | 0.351 | 0.326 | Peptidyltransferase inhibitor | 0.183 0.123 DBMET00103 0.247 0.053 DBMET00104 0.326 0.017 DBMET00105 0.232 0.065 DBMET01211 | DBMET00105 | |
| 0.022 | 0.262 | 0.055 | Topoisomerase II beta inhibitor | 0.055 0.026 DBMET00103 | DBMET00103 | |
| 0.036 | 0.277 | 0.061 | Transcription factor RelA inhibitor | 0.061 0.053 DBMET01676 | DBMET01676 | |
| 0.04 | 0.282 | 0.121 | MAP kinase 13 inhibitor | 0.121 0.055 DBMET00333 0.121 0.055 DBMET01212 | DBMET01212 | |
| 0.068 | 0.311 | 0.301 | Insulin secretagoues | 0.301 0.012 DBMET00105 0.228 0.025 DBMET01676 0.226 0.025 DBMET00252 | DBMET00105 | |
| 0.006 | 0.249 | 0.023 | Leukotriene B4 receptor 2 antagonist | 0.023 0.014 DBMET01676 | DBMET01676 | |
| 0.021 | 0.266 | 0.04 | Integrin alpha1beta1 antagonist | 0.04 0.02 DBMET01676 0.038 0.026 DBMET00252 | DBMET01676 | |
| 0.138 | 0.383 | 0.62 | Cyclophilin D inhibitor | 0.317 0.148 DBMET00104 0.596 0.028 DBMET00105 0.529 0.042 DBMET01676 0.62 0.024 DBMET00252 0.375 0.106 DBMET01211 | DBMET00252 | |
| 0.004 | 0.249 | 0.064 | Prostaglandin D2 antagonist | 0.064 0.005 DBMET01676 0.049 0.007 DBMET00252 | DBMET01676 | |
| 0.018 | 0.265 | 0.095 | Na+ K+ transporting ATPase inhibitor | 0.095 0.036 DBMET00103 0.071 0.059 DBMET01676 | DBMET00103 | |
| 0.008 | 0.255 | 0.03 | Cholesterol ester transfer protein antagonist | 0.029 0.025 DBMET01676 0.03 0.024 DBMET00252 | DBMET00252 | |
| 0.023 | 0.272 | 0.142 | Prostaglandin F2 alpha antagonist | 0.12 0.007 DBMET01676 0.142 0.005 DBMET00252 | DBMET00252 | |
| 0.04 | 0.29 | 0.158 | Lipid peroxidase inhibitor | 0.158 0.063 DBMET00105 | DBMET00105 | |
| 0.013 | 0.264 | 0.192 | Argininosuccinate synthase inhibitor | 0.192 0.008 DBMET01676 0.17 0.01 DBMET00252 | DBMET01676 | |
| 0.014 | 0.267 | 0.058 | Pim-2 kinase inhibitor | 0.058 0.032 DBMET00103 | DBMET00103 | |
| 0.015 | 0.27 | 0.073 | Protein 50S ribosomal subunit inhibitor | 0.073 0.023 DBMET00105 | DBMET00105 | |
| 0.01 | 0.264 | 0.049 | Metalloproteinase-3 inhibitor | 0.049 0.035 DBMET01676 | DBMET01676 | |
| 0.07 | 0.326 | 0.155 | 3C-like protease (Human coronavirus) inhibitor | 0.155 0.094 DBMET00333 0.152 0.098 DBMET00103 0.155 0.094 DBMET01212 | DBMET01212 | |
| 0.003 | 0.26 | 0.02 | Alpha 2a adrenoreceptor agonist | 0.02 0.009 DBMET01211 | DBMET01211 | |
| 0.038 | 0.295 | 0.122 | MAP kinase 12 inhibitor | 0.122 0.068 DBMET00333 0.122 0.068 DBMET01212 | DBMET01212 | |
| 0.05 | 0.311 | 0.123 | TRPA1 agonist | 0.123 0.055 DBMET01676 0.101 0.086 DBMET00252 | DBMET01676 | |
| 0.016 | 0.277 | 0.089 | Glutamate (mGluR8) agonist | 0.089 0.003 DBMET01676 0.081 0.004 DBMET00252 | DBMET01676 | |
| 0.028 | 0.289 | 0.195 | Glutamate dehydrogenase inhibitor | 0.072 0.054 DBMET00103 0.195 0.01 DBMET01676 0.173 0.013 DBMET00252 | DBMET01676 | |
| 0.01 | 0.273 | 0.087 | Aldose reductase inhibitor | 0.077 0.024 DBMET01676 0.087 0.021 DBMET00252 | DBMET00252 | |
| 0.005 | 0.268 | 0.029 | Methionyl aminopeptidase 1 inhibitor | 0.029 0.028 DBMET01211 | DBMET01211 | |
| 0.049 | 0.313 | 0.078 | 3C-Like protease (SARS coronavirus) inhibitor | 0.078 0.075 DBMET00103 | DBMET00103 | |
| 0.029 | 0.294 | 0.101 | Caspase 7 inhibitor | 0.082 0.056 DBMET00333 0.101 0.027 DBMET01676 0.082 0.056 DBMET00252 0.082 0.056 DBMET01212 | DBMET01676 | |
| 0.021 | 0.287 | 0.065 | Beta adrenoreceptor antagonist | 0.065 0.046 DBMET00103 | DBMET00103 | |
| 0.017 | 0.283 | 0.045 | Histamine H4 receptor antagonist | 0.045 0.041 DBMET00103 | DBMET00103 | |
| 0.081 | 0.349 | 0.541 | Hypoglycemic | 0.541 0.012 DBMET00105 0.46 0.019 DBMET01676 0.486 0.016 DBMET00252 0.186 0.127 DBMET01211 | DBMET00105 | |
| 0.058 | 0.327 | 0.138 | Hexokinase inhibitor | 0.138 0.094 DBMET00103 0.126 0.11 DBMET00105 0.132 0.101 DBMET01676 | DBMET00103 | |
| 0.017 | 0.286 | 0.169 | Phenylalanine 4-hydroxylase inhibitor | 0.079 0.038 DBMET00103 0.169 0.009 DBMET01676 0.129 0.016 DBMET00252 0.087 0.033 DBMET01211 | DBMET01676 | |
| 0.012 | 0.283 | 0.068 | Macrophage colony-stimulating factor 1 receptor antagonist | 0.068 0.055 DBMET00103 | DBMET00103 | |
| 0.017 | 0.288 | 0.224 | Monophenol monooxygenase inhibitor | 0.224 0.028 DBMET01676 0.184 0.037 DBMET00252 | DBMET01676 | |
| 0.014 | 0.286 | 0.059 | Matrix metalloproteinase inhibitor | 0.059 0.056 DBMET01676 | DBMET01676 | |
| 0.03 | 0.302 | 0.221 | Bronchodilator | 0.221 0.015 DBMET00104 0.219 0.016 DBMET01211 | DBMET00104 | |
| 0.019 | 0.292 | 0.22 | Protein-tyrosine phosphatase 1B inhibitor | 0.22 0.024 DBMET01676 0.206 0.028 DBMET00252 | DBMET01676 | |
| 0.039 | 0.312 | 0.111 | Beta amyloid protein antagonist | 0.107 0.08 DBMET00252 0.111 0.076 DBMET01211 | DBMET01211 | |
| 0.008 | 0.282 | 0.067 | Prostaglandin E2 antagonist | 0.05 0.035 DBMET01676 0.067 0.025 DBMET00252 0.063 0.027 DBMET01211 | DBMET00252 | |
| 0.02 | 0.293 | 0.046 | Beta adrenoreceptor agonist | 0.046 0.029 DBMET01211 | DBMET01211 | |
| 0.004 | 0.278 | 0.049 | Leukotriene B4 receptor 1 antagonist | 0.049 0.007 DBMET01676 0.041 0.011 DBMET00252 0.025 0.022 DBMET01211 | DBMET01676 | |
| 0.081 | 0.356 | 0.212 | 12-Lipoxygenase inhibitor | 0.212 0.138 DBMET01676 | DBMET01676 | |
| 0.007 | 0.282 | 0.044 | Guanylate cyclase inhibitor | 0.044 0.028 DBMET01676 0.044 0.028 DBMET00252 | DBMET00252 | |
| 0.006 | 0.282 | 0.03 | Nicotinic acid receptor 2 antagonist | 0.028 0.016 DBMET01676 0.03 0.013 DBMET00252 | DBMET00252 | |
| 0.025 | 0.301 | 0.105 | Pim-3 kinase inhibitor | 0.105 0.041 DBMET00103 | DBMET00103 | |
| 0.009 | 0.287 | 0.191 | Prostaglandin antagonist | 0.191 0.007 DBMET01676 0.187 0.008 DBMET00252 0.053 0.037 DBMET01211 | DBMET01676 | |
| 0.013 | 0.292 | 0.04 | Protein kinase (CK2) beta inhibitor | 0.04 0.012 DBMET00103 | DBMET00103 | |
| 0.029 | 0.308 | 0.094 | Peroxisome proliferator-activated receptor gamma antagonist | 0.094 0.019 DBMET01676 0.092 0.021 DBMET00252 0.083 0.03 DBMET01211 | DBMET01676 | |
| 0.009 | 0.289 | 0.053 | Glutamate (mGluR1) agonist | 0.053 0.005 DBMET01676 0.031 0.009 DBMET00252 | DBMET01676 | |
| 0.028 | 0.309 | 0.117 | Topoisomerase II inhibitor | 0.117 0.069 DBMET00105 | DBMET00105 | |
| 0.004 | 0.286 | 0.059 | Prostaglandin EP3 antagonist | 0.039 0.014 DBMET01676 0.059 0.008 DBMET00252 | DBMET00252 | |
| 0.045 | 0.326 | 0.233 | Photosensitizer | 0.233 0.008 DBMET01676 0.186 0.016 DBMET00252 | DBMET01676 | |
| 0.005 | 0.287 | 0.025 | Imidazoline I1 receptor antagonist | 0.025 0.01 DBMET00103 | DBMET00103 | |
| 0.058 | 0.343 | 0.372 | Free radical scavenger | 0.372 0.034 DBMET00105 0.208 0.091 DBMET01676 0.185 0.11 DBMET00252 | DBMET00105 | |
| 0.009 | 0.294 | 0.081 | Neutrophil collagenase inhibitor | 0.081 0.031 DBMET01676 0.07 0.039 DBMET00252 | DBMET01676 | |
| 0.003 | 0.289 | 0.045 | Free fatty acid receptor 1 agonist | 0.045 0.005 DBMET01676 0.043 0.005 DBMET00252 | DBMET01676 | |
| 0.037 | 0.327 | 0.341 | Alpha-N-acetylglucosaminidase inhibitor | 0.202 0.033 DBMET00103 0.341 0.012 DBMET01676 0.304 0.016 DBMET00252 | DBMET01676 | |
| 0.045 | 0.337 | 0.162 | Diuretic | 0.162 0.068 DBMET01676 0.141 0.085 DBMET00252 | DBMET01676 | |
| 0.015 | 0.307 | 0.051 | Beta 2 adrenoreceptor antagonist | 0.051 0.035 DBMET00103 | DBMET00103 | |
| 0.001 | 0.294 | 0.02 | Glutamate (mGluR6) agonist | 0.02 0.004 DBMET01676 0.02 0.004 DBMET00252 | DBMET00252 | |
| 0.006 | 0.299 | 0.015 | Integrin beta6 antagonist | 0.014 0.01 DBMET01676 0.015 0.009 DBMET00252 | DBMET00252 | |
| 0.049 | 0.342 | 0.205 | Interleukin 4 antagonist | 0.167 0.037 DBMET00104 0.205 0.021 DBMET01211 | DBMET01211 | |
| 0.063 | 0.358 | 0.243 | Growth hormone agonist | 0.243 0.045 DBMET01676 0.216 0.053 DBMET00252 | DBMET01676 | |
| 0.034 | 0.329 | 0.268 | Protein-tyrosine phosphatase inhibitor | 0.268 0.026 DBMET01676 0.253 0.03 DBMET00252 | DBMET01676 | |
| 0.033 | 0.329 | 0.112 | Alkaline phosphatase inhibitor | 0.112 0.097 DBMET01676 | DBMET01676 | |
| 0.022 | 0.321 | 0.255 | Alcohol dehydrogenase inhibitor | 0.111 0.042 DBMET00333 0.226 0.01 DBMET01676 0.255 0.007 DBMET00252 0.092 0.062 DBMET01211 0.111 0.042 DBMET01212 | DBMET00252 | |
| 0.018 | 0.319 | 0.081 | Glutamate (mGluR group III) antagonist | 0.081 0.007 DBMET01676 0.072 0.009 DBMET00252 | DBMET01676 | |
| 0.066 | 0.366 | 0.161 | CF transmembrane conductance regulator agonist | 0.161 0.059 DBMET00103 | DBMET00103 | |
| 0.015 | 0.316 | 0.159 | Sphingosine 1-phosphate receptor 4 agonist | 0.159 0.007 DBMET01676 0.126 0.015 DBMET00252 | DBMET01676 | |
| 0.005 | 0.307 | 0.107 | 5 Hydroxytryptamine 2C agonist | 0.107 0.007 DBMET00103 0.045 0.031 DBMET00106 | DBMET00103 | |
| 0.002 | 0.304 | 0.018 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.018 0.008 DBMET01676 0.015 0.01 DBMET00252 | DBMET01676 | |
| 0.018 | 0.32 | 0.05 | Guanylate cyclase stimulant | 0.043 0.03 DBMET01676 0.05 0.021 DBMET00252 | DBMET00252 | |
| 0.039 | 0.344 | 0.178 | Interleukin 5 antagonist | 0.148 0.012 DBMET00104 0.178 0.007 DBMET01211 | DBMET01211 | |
| 0.096 | 0.4 | 0.27 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.27 0.088 DBMET00333 0.203 0.154 DBMET00106 0.27 0.088 DBMET01212 | DBMET01212 | |
| 0.063 | 0.367 | 0.41 | Antioxidant | 0.41 0.033 DBMET00105 0.226 0.098 DBMET01676 0.209 0.108 DBMET00252 | DBMET00105 | |
| 0.09 | 0.395 | 0.129 | CC chemokine 6 receptor antagonist | 0.129 0.074 DBMET00105 | DBMET00105 | |
| 0.015 | 0.32 | 0.074 | Histidine decarboxylase inhibitor | 0.074 0.047 DBMET00103 0.073 0.048 DBMET01676 | DBMET00103 | |
| 0.036 | 0.341 | 0.085 | MAP kinase kinase 7 inhibitor | 0.085 0.034 DBMET00103 | DBMET00103 | |
| 0.004 | 0.31 | 0.053 | Urate transporter 1 inhibitor | 0.053 0.017 DBMET01676 0.047 0.021 DBMET00252 | DBMET01676 | |
| 0.027 | 0.333 | 0.189 | Gastric antisecretory | 0.1 0.066 DBMET00333 0.097 0.07 DBMET00106 0.189 0.014 DBMET01676 0.159 0.023 DBMET00252 0.1 0.066 DBMET01212 | DBMET01676 | |
| 0.037 | 0.346 | 0.303 | Pyruvate kinase inhibitor | 0.294 0.049 DBMET01676 0.303 0.047 DBMET00252 | DBMET00252 | |
| 0.047 | 0.357 | 0.271 | Interleukin antagonist | 0.171 0.103 DBMET00104 0.271 0.055 DBMET01676 0.228 0.07 DBMET00252 0.258 0.059 DBMET01211 | DBMET01676 | |
| 0.013 | 0.326 | 0.028 | DNA topoisomerase IV inhibitor | 0.028 0.027 DBMET01211 | DBMET01211 | |
| 0.008 | 0.323 | 0.041 | Peroxisome proliferator-activated receptor delta antagonist | 0.041 0.014 DBMET01676 0.038 0.017 DBMET00252 | DBMET01676 | |
| 0.018 | 0.336 | 0.081 | Metalloproteinase-2 inhibitor | 0.081 0.051 DBMET01676 0.071 0.064 DBMET00252 | DBMET01676 | |
| 0.058 | 0.377 | 0.354 | Tumour necrosis factor alpha release inhibitor | 0.228 0.087 DBMET00105 0.354 0.037 DBMET00106 | DBMET00106 | |
| 0.086 | 0.407 | 0.24 | Immunomodulator | 0.24 0.123 DBMET00105 | DBMET00105 | |
| 0.01 | 0.332 | 0.127 | Peroxisome proliferator-activated receptor gamma agonist | 0.127 0.018 DBMET01676 0.116 0.021 DBMET00252 | DBMET01676 | |
| 0.005 | 0.327 | 0.044 | Geranyltranstransferase inhibitor | 0.039 0.038 DBMET00333 0.039 0.038 DBMET01676 0.044 0.03 DBMET00252 0.039 0.038 DBMET01212 | DBMET00252 | |
| 0.097 | 0.419 | 0.136 | Heat shock protein 70 antagonist | 0.129 0.128 DBMET00103 0.136 0.093 DBMET01676 | DBMET01676 | |
| 0.017 | 0.343 | 0.116 | Aminopeptidase I inhibitor | 0.116 0.021 DBMET01676 0.106 0.025 DBMET00252 | DBMET01676 | |
| 0.01 | 0.336 | 0.199 | Phosphofructokinase-1 inhibitor | 0.199 0.011 DBMET01676 0.181 0.013 DBMET00252 | DBMET01676 | |
| 0.034 | 0.36 | 0.104 | Bromodomain-containing protein 2 inhibitor | 0.087 0.062 DBMET00333 0.104 0.036 DBMET00103 0.081 0.073 DBMET01211 0.087 0.062 DBMET01212 | DBMET00103 | |
| 0.016 | 0.343 | 0.057 | Potassium channel small-conductance Ca-activated blocker | 0.057 0.019 DBMET00333 0.041 0.039 DBMET01211 0.057 0.019 DBMET01212 | DBMET01212 | |
| 0.074 | 0.402 | 0.238 | Histone acetyltransferase inhibitor | 0.217 0.047 DBMET01676 0.238 0.031 DBMET00252 | DBMET00252 | |
| 0.038 | 0.366 | 0.195 | Electron transport complex I inhibitor | 0.164 0.015 DBMET00104 0.195 0.009 DBMET01211 | DBMET01211 | |
| 0.017 | 0.347 | 0.064 | Glutamate (mGluR4) antagonist | 0.064 0.012 DBMET01676 0.063 0.013 DBMET00252 | DBMET01676 | |
| 0.007 | 0.34 | 0.138 | Antineoplastic antibiotic | 0.138 0.034 DBMET00105 | DBMET00105 | |
| 0.132 | 0.467 | 0.215 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.215 0.126 DBMET00103 | DBMET00103 | |
| 0.032 | 0.371 | 0.109 | Microtubule formation inhibitor | 0.098 0.094 DBMET00103 0.109 0.076 DBMET01676 0.099 0.093 DBMET00252 | DBMET01676 | |
| 0.019 | 0.359 | 0.076 | Protease 3C (Human rhinovirus) inhibitor | 0.076 0.031 DBMET01676 0.071 0.036 DBMET00252 | DBMET01676 | |
| 0.033 | 0.373 | 0.13 | Electrolyte absorption antagonist | 0.126 0.032 DBMET00103 0.13 0.029 DBMET01676 0.115 0.04 DBMET00252 | DBMET01676 | |
| 0.005 | 0.346 | 0.025 | Retinoid X beta receptor antagonist | 0.025 0.007 DBMET01676 0.022 0.01 DBMET00252 | DBMET01676 | |
| 0.01 | 0.353 | 0.037 | Retinoic acid alpha receptor agonist | 0.037 0.032 DBMET01676 | DBMET01676 | |
| 0.004 | 0.348 | 0.028 | Lysine carboxypeptidase inhibitor | 0.028 0.017 DBMET01676 0.025 0.021 DBMET00252 | DBMET01676 | |
| 0.005 | 0.35 | 0.036 | Lysophosphatidic acid 1 receptor antagonist | 0.034 0.005 DBMET01676 0.03 0.006 DBMET00252 0.036 0.005 DBMET01211 | DBMET01211 | |
| 0.024 | 0.37 | 0.086 | ATPase (Vacuolar H+) inhibitor | 0.086 0.065 DBMET00105 | DBMET00105 | |
| 0.026 | 0.373 | 0.133 | Cell adhesion molecule inhibitor | 0.075 0.06 DBMET00105 0.133 0.019 DBMET01676 0.098 0.036 DBMET00252 | DBMET01676 | |
| 0.051 | 0.399 | 0.22 | GABA C receptor rho-2 antagonist | 0.22 0.02 DBMET00103 | DBMET00103 | |
| 0.01 | 0.359 | 0.043 | Dihydroorotase inhibitor | 0.043 0.033 DBMET01676 | DBMET01676 | |
| 0.007 | 0.356 | 0.048 | Leukocyte elastase inhibitor | 0.048 0.025 DBMET01676 0.038 0.035 DBMET00252 | DBMET01676 | |
| 0.022 | 0.371 | 0.059 | Corticotropin releasing factor 2 receptor antagonist | 0.059 0.049 DBMET00103 | DBMET00103 | |
| 0.005 | 0.358 | 0.085 | Ornithine carbamoyltransferase inhibitor | 0.085 0.02 DBMET01676 0.075 0.023 DBMET00252 | DBMET01676 | |
| 0.019 | 0.373 | 0.106 | Topoisomerase I inhibitor | 0.106 0.065 DBMET00105 | DBMET00105 | |
| 0.018 | 0.373 | 0.101 | Carbonic anhydrase XIII inhibitor | 0.101 0.037 DBMET01676 0.082 0.049 DBMET00252 | DBMET01676 | |
| 0.057 | 0.414 | 0.136 | MAP kinase 3 inhibitor | 0.126 0.118 DBMET00333 0.132 0.103 DBMET00103 0.136 0.094 DBMET00106 0.127 0.115 DBMET01211 0.126 0.118 DBMET01212 | DBMET00106 | |
| 0.107 | 0.465 | 0.26 | MAP kinase 1 inhibitor | 0.26 0.222 DBMET00333 0.26 0.222 DBMET01212 | DBMET01212 | |
| 0.017 | 0.38 | 0.106 | Protein kinase C zeta inhibitor | 0.106 0.044 DBMET00103 | DBMET00103 | |
| 0.004 | 0.367 | 0.051 | Fructose-1,6-bisphosphatase inhibitor | 0.05 0.025 DBMET01676 0.051 0.024 DBMET00252 | DBMET00252 | |
| 0.012 | 0.377 | 0.04 | VCAM antagonist | 0.04 0.026 DBMET01676 0.037 0.035 DBMET00252 | DBMET01676 | |
| 0.023 | 0.39 | 0.17 | Aminopeptidase B inhibitor | 0.17 0.03 DBMET01676 0.157 0.035 DBMET00252 | DBMET01676 | |
| 0.012 | 0.379 | 0.04 | VCAM-1 antagonist | 0.04 0.026 DBMET01676 0.037 0.036 DBMET00252 | DBMET01676 | |
| 0.017 | 0.384 | 0.067 | Heparanase inhibitor | 0.057 0.028 DBMET00105 0.065 0.017 DBMET01676 0.067 0.014 DBMET00252 | DBMET00252 | |
| 0.044 | 0.413 | 0.216 | Calpain inhibitor | 0.216 0.098 DBMET01676 0.18 0.135 DBMET00252 | DBMET01676 | |
| 0.041 | 0.41 | 0.096 | Estrogen-related receptor beta agonist | 0.096 0.03 DBMET01676 0.091 0.04 DBMET00252 | DBMET01676 | |
| 0.007 | 0.376 | 0.019 | Methylmalonyl-CoA mutase inhibitor | 0.019 0.011 DBMET01676 0.018 0.014 DBMET00252 | DBMET01676 | |
| 0.015 | 0.385 | 0.068 | I kappa B kinase 2 inhibitor | 0.068 0.034 DBMET00103 | DBMET00103 | |
| 0.013 | 0.384 | 0.037 | ADAM10 endopeptidase inhibitor | 0.037 0.018 DBMET00106 | DBMET00106 | |
| 0.054 | 0.424 | 0.198 | DNA damaging | 0.17 0.145 DBMET00333 0.195 0.12 DBMET01676 0.198 0.117 DBMET00252 0.17 0.145 DBMET01212 | DBMET00252 | |
| 0.008 | 0.379 | 0.085 | NMDA receptor glycine site agonist | 0.085 0.025 DBMET00103 | DBMET00103 | |
| 0.011 | 0.382 | 0.074 | Diacylglycerol O-acyltransferase inhibitor | 0.07 0.02 DBMET01676 0.074 0.017 DBMET00252 | DBMET00252 | |
| 0.03 | 0.403 | 0.131 | Cathepsin H inhibitor | 0.131 0.063 DBMET01676 0.104 0.099 DBMET00252 | DBMET01676 | |
| 0.015 | 0.391 | 0.087 | NMDA receptor agonist | 0.087 0.025 DBMET00103 0.084 0.026 DBMET01676 0.068 0.038 DBMET00252 | DBMET00103 | |
| 0.01 | 0.387 | 0.068 | Collagenase 3 inhibitor | 0.068 0.033 DBMET01676 0.066 0.035 DBMET00252 | DBMET01676 | |
| 0.008 | 0.386 | 0.115 | Alcohol oxidase inhibitor | 0.115 0.015 DBMET01676 0.092 0.02 DBMET00252 | DBMET01676 | |
| 0.001 | 0.379 | 0.014 | Carbonic anhydrase XI inhibitor | 0.014 0.007 DBMET01676 | DBMET01676 | |
| 0.01 | 0.388 | 0.035 | Tryptophan 5 hydroxylase inhibitor | 0.035 0.027 DBMET01676 | DBMET01676 | |
| 0.065 | 0.444 | 0.284 | 15-Lipoxygenase inhibitor | 0.284 0.141 DBMET01676 0.23 0.182 DBMET00252 | DBMET01676 | |
| 0.016 | 0.396 | 0.088 | Cyclin B3 inhibitor | 0.088 0.034 DBMET00106 | DBMET00106 | |
| 0.003 | 0.385 | 0.039 | Nicotinic alpha3beta4 receptor agonist | 0.039 0.011 DBMET00103 | DBMET00103 | |
| 0.027 | 0.408 | 0.207 | GABA C receptor rho-1 antagonist | 0.207 0.007 DBMET00103 0.091 0.077 DBMET01676 | DBMET00103 | |
| 0.003 | 0.385 | 0.043 | Retinoid X receptor agonist | 0.043 0.021 DBMET01676 0.042 0.021 DBMET00252 | DBMET01676 | |
| 0.008 | 0.389 | 0.07 | Acyl-CoA dehydrogenase inhibitor | 0.07 0.027 DBMET01676 0.061 0.032 DBMET00252 | DBMET01676 | |
| 0.013 | 0.395 | 0.055 | Antibiotic Aminoglycoside-like | 0.055 0.01 DBMET00105 | DBMET00105 | |
| 0.005 | 0.387 | 0.027 | Retinoid X gamma receptor antagonist | 0.027 0.018 DBMET01676 | DBMET01676 | |
| 0.077 | 0.459 | 0.525 | Antibacterial | 0.525 0.034 DBMET00105 0.283 0.148 DBMET01676 0.254 0.173 DBMET00252 0.314 0.125 DBMET01211 | DBMET00105 | |
| 0.01 | 0.392 | 0.04 | Glutamate (mGluR4) agonist | 0.04 0.015 DBMET01676 0.035 0.021 DBMET00252 | DBMET01676 | |
| 0.036 | 0.419 | 0.246 | Immunostimulant | 0.246 0.098 DBMET00105 0.203 0.119 DBMET01676 0.159 0.147 DBMET00252 | DBMET00105 | |
| 0.032 | 0.419 | 0.42 | Angiogenesis stimulant | 0.42 0.019 DBMET00105 0.291 0.053 DBMET01676 0.256 0.067 DBMET00252 | DBMET00105 | |
| 0.007 | 0.398 | 0.029 | Calcitonin receptor agonist | 0.029 0.028 DBMET01676 | DBMET01676 | |
| 0.009 | 0.4 | 0.135 | Biliverdin reductase inhibitor | 0.135 0.011 DBMET01676 0.118 0.014 DBMET00252 | DBMET01676 | |
| 0.011 | 0.405 | 0.287 | Porphobilinogen synthase inhibitor | 0.287 0.005 DBMET01676 0.247 0.008 DBMET00252 | DBMET01676 | |
| 0.007 | 0.401 | 0.061 | Macrophage elastase inhibitor | 0.061 0.018 DBMET01676 0.055 0.021 DBMET00252 | DBMET01676 | |
| 0.051 | 0.447 | 0.092 | Factor V inhibitor | 0.092 0.091 DBMET01676 | DBMET01676 | |
| 0.031 | 0.43 | 0.102 | Granulocyte macrophage colony stimulating factor agonist | 0.102 0.032 DBMET01676 0.095 0.042 DBMET00252 | DBMET01676 | |
| 0.03 | 0.428 | 0.117 | Antibacterial (Helicobacter pylori) | 0.117 0.087 DBMET01211 | DBMET01211 | |
| 0.016 | 0.419 | 0.09 | Glutamate (mGluR7) antagonist | 0.09 0.018 DBMET01676 0.086 0.02 DBMET00252 | DBMET01676 | |
| 0.092 | 0.495 | 0.382 | Apoptosis agonist | 0.382 0.122 DBMET00105 0.236 0.23 DBMET01676 | DBMET00105 | |
| 0.012 | 0.416 | 0.07 | Glutamate (mGluR group III) agonist | 0.07 0.015 DBMET01676 0.05 0.023 DBMET00252 | DBMET01676 | |
| 0.027 | 0.432 | 0.114 | Xanthine oxidase inhibitor | 0.114 0.05 DBMET01676 0.092 0.068 DBMET00252 | DBMET01676 | |
| 0.025 | 0.431 | 0.075 | ErbB-3 antagonist | 0.075 0.068 DBMET01676 | DBMET01676 | |
| 0.022 | 0.429 | 0.059 | DNA helicase inhibitor | 0.059 0.03 DBMET01676 0.055 0.037 DBMET00252 | DBMET01676 | |
| 0.031 | 0.437 | 0.13 | DNA polymerase I inhibitor | 0.13 0.061 DBMET01676 0.113 0.074 DBMET00252 | DBMET01676 | |
| 0.036 | 0.443 | 0.195 | Peroxidase inhibitor | 0.195 0.06 DBMET00103 0.186 0.063 DBMET01676 0.146 0.08 DBMET00252 | DBMET00103 | |
| 0.001 | 0.411 | 0.007 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.007 0.005 DBMET01676 0.007 0.005 DBMET00252 | DBMET00252 | |
| 0.005 | 0.415 | 0.039 | Retinoid X alpha receptor agonist | 0.039 0.02 DBMET01676 0.038 0.021 DBMET00252 | DBMET01676 | |
| 0.022 | 0.439 | 0.151 | Interleukin 1 beta converting enzyme inhibitor | 0.151 0.017 DBMET01676 0.146 0.019 DBMET00252 | DBMET01676 | |
| 0.038 | 0.461 | 0.169 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.169 0.105 DBMET00333 0.169 0.105 DBMET01212 | DBMET01212 | |
| 0.031 | 0.468 | 0.163 | Cell adhesion inhibitor | 0.124 0.062 DBMET00105 0.163 0.039 DBMET01676 0.135 0.056 DBMET00252 | DBMET01676 | |
| 0.002 | 0.441 | 0.016 | Nicotinic alpha4 receptor agonist | 0.016 0.013 DBMET00103 | DBMET00103 | |
| 0.022 | 0.463 | 0.127 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.127 0.109 DBMET00333 0.127 0.109 DBMET01212 | DBMET01212 | |
| 0.025 | 0.466 | 0.091 | Caspase 9 inhibitor | 0.082 0.022 DBMET01676 0.091 0.017 DBMET00252 | DBMET00252 | |
| 0.036 | 0.484 | 0.171 | Hemostatic | 0.145 0.074 DBMET00105 0.16 0.057 DBMET01676 0.171 0.048 DBMET00252 | DBMET00252 | |
| 0.008 | 0.458 | 0.114 | Plasminogen activator inhibitor antagonist | 0.11 0.009 DBMET01676 0.114 0.008 DBMET00252 | DBMET00252 | |
| 0.006 | 0.458 | 0.043 | Toll-Like receptor 2 agonist | 0.043 0.027 DBMET01676 0.037 0.033 DBMET00252 | DBMET01676 | |
| 0.037 | 0.491 | 0.204 | Adenylate kinase inhibitor | 0.204 0.014 DBMET01676 0.182 0.018 DBMET00252 | DBMET01676 | |
| 0.027 | 0.483 | 0.1 | Nav1.4 sodium channel blocker | 0.1 0.075 DBMET01676 | DBMET01676 | |
| 0.004 | 0.463 | 0.034 | DNA gyrase subunit B inhibitor | 0.034 0.033 DBMET01211 | DBMET01211 | |
| 0.017 | 0.477 | 0.12 | Ornithine decarboxylase inhibitor | 0.12 0.026 DBMET01676 0.109 0.035 DBMET00252 | DBMET01676 | |
| 0.003 | 0.464 | 0.065 | Antimetabolite | 0.065 0.024 DBMET01676 0.056 0.027 DBMET00252 | DBMET01676 | |
| 0.011 | 0.472 | 0.083 | Carbonic anhydrase stimulant | 0.083 0.024 DBMET01676 0.072 0.03 DBMET00252 | DBMET01676 | |
| 0.029 | 0.501 | 0.108 | Cytokine production inhibitor | 0.108 0.102 DBMET01676 | DBMET01676 | |
| 0.005 | 0.477 | 0.073 | Thymidylate synthase inhibitor | 0.073 0.01 DBMET01676 0.071 0.011 DBMET00252 | DBMET01676 | |
| 0.005 | 0.477 | 0.027 | Thyroid hormone agonist | 0.027 0.017 DBMET01676 | DBMET01676 | |
| 0.003 | 0.478 | 0.029 | Nicotinic alpha4beta2 receptor agonist | 0.029 0.019 DBMET00103 | DBMET00103 | |
| 0.038 | 0.522 | 0.097 | Interleukin 12 antagonist | 0.092 0.068 DBMET01676 0.097 0.059 DBMET00252 | DBMET00252 | |
| 0.007 | 0.492 | 0.048 | Membrane dipeptidase inhibitor | 0.048 0.017 DBMET01676 0.043 0.022 DBMET00252 | DBMET01676 | |
| 0.013 | 0.499 | 0.079 | I kappa B kinase inhibitor | 0.079 0.063 DBMET00103 | DBMET00103 | |
| 0.007 | 0.494 | 0.22 | Selectin antagonist | 0.22 0.01 DBMET00105 | DBMET00105 | |
| 0.007 | 0.497 | 0.032 | Caspase 6 inhibitor | 0.029 0.026 DBMET01676 0.032 0.017 DBMET00252 | DBMET00252 | |
| 0.028 | 0.519 | 0.243 | Platelet aggregation inhibitor | 0.243 0.055 DBMET01676 0.208 0.076 DBMET00252 | DBMET01676 | |
| 0.011 | 0.502 | 0.081 | Secretase beta inhibitor | 0.081 0.035 DBMET01211 | DBMET01211 | |
| 0.01 | 0.502 | 0.124 | Expectorant | 0.124 0.048 DBMET01676 0.105 0.063 DBMET00252 | DBMET01676 | |
| 0.005 | 0.497 | 0.026 | Lysophosphatidic acid receptor 1 agonist | 0.026 0.016 DBMET01676 0.024 0.02 DBMET00252 | DBMET01676 | |
| 0.024 | 0.52 | 0.107 | Carbonic anhydrase III inhibitor | 0.107 0.054 DBMET01676 0.089 0.076 DBMET00252 | DBMET01676 | |
| 0.015 | 0.518 | 0.096 | Protein kinase C gamma inhibitor | 0.096 0.084 DBMET00103 | DBMET00103 | |
| 0.061 | 0.563 | 0.371 | Sodium/bile acid cotransporter inhibitor | 0.371 0.028 DBMET01676 0.359 0.034 DBMET00252 | DBMET01676 | |
| 0.012 | 0.516 | 0.094 | MAP-kinase-activated kinase 2 inhibitor | 0.094 0.032 DBMET00103 | DBMET00103 | |
| 0.019 | 0.525 | 0.077 | Carbonic anhydrase VI inhibitor | 0.077 0.061 DBMET01676 | DBMET01676 | |
| 0.011 | 0.517 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.022 DBMET00105 | DBMET00105 | |
| 0.018 | 0.525 | 0.104 | Keratolytic | 0.104 0.028 DBMET01676 0.102 0.029 DBMET00252 | DBMET01676 | |
| 0.005 | 0.514 | 0.029 | Caspase 2 inhibitor | 0.028 0.025 DBMET01676 0.029 0.024 DBMET00252 | DBMET00252 | |
| 0.013 | 0.524 | 0.15 | Mucolytic | 0.15 0.032 DBMET01676 0.131 0.045 DBMET00252 | DBMET01676 | |
| 0.01 | 0.521 | 0.098 | Alkylator | 0.098 0.091 DBMET01676 | DBMET01676 | |
| 0.018 | 0.532 | 0.088 | Uric acid excretion stimulant | 0.088 0.068 DBMET01676 | DBMET01676 | |
| 0.007 | 0.531 | 0.067 | Lysophosphatidic acid 3 receptor antagonist | 0.067 0.017 DBMET01676 0.06 0.023 DBMET00252 | DBMET01676 | |
| 0.001 | 0.53 | 0.021 | Carbonic anhydrase X inhibitor | 0.021 0.008 DBMET01676 0.018 0.01 DBMET00252 | DBMET01676 | |
| 0.001 | 0.53 | 0.021 | Carbonic anhydrase VIII inhibitor | 0.021 0.008 DBMET01676 0.018 0.01 DBMET00252 | DBMET01676 | |
| 0.009 | 0.538 | 0.069 | Carbonic anhydrase VA inhibitor | 0.069 0.047 DBMET01676 | DBMET01676 | |
| 0.015 | 0.547 | 0.102 | MAP-kinase-activated kinase inhibitor | 0.102 0.038 DBMET00103 | DBMET00103 | |
| 0.003 | 0.541 | 0.042 | GP IIb/IIIa receptor antagonist | 0.042 0.04 DBMET01676 | DBMET01676 | |
| 0.007 | 0.554 | 0.059 | Carbonic anhydrase V inhibitor | 0.059 0.054 DBMET01676 | DBMET01676 | |
| 0.035 | 0.592 | 0.195 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.195 0.076 DBMET01676 0.166 0.114 DBMET00252 | DBMET01676 | |
| 0.048 | 0.614 | 0.299 | Insulysin inhibitor | 0.299 0.059 DBMET01676 0.265 0.083 DBMET00252 | DBMET01676 | |
| 0.007 | 0.606 | 0.059 | DNA gyrase inhibitor | 0.059 0.051 DBMET01211 | DBMET01211 | |
| 0.088 | 0.692 | 0.406 | Calcium channel L-type activator | 0.266 0.188 DBMET00103 0.378 0.097 DBMET00104 0.406 0.077 DBMET01211 | DBMET01211 | |
| 0.014 | 0.661 | 0.064 | Factor IXa inhibitor | 0.064 0.024 DBMET01211 | DBMET01211 | |
| 0.012 | 0.68 | 0.207 | Thrombolytic | 0.156 0.078 DBMET00105 0.201 0.051 DBMET01676 0.207 0.048 DBMET00252 | DBMET00252 | |
| 0.031 | 0.742 | 0.143 | Folate antagonist | 0.143 0.025 DBMET01676 0.142 0.025 DBMET00252 | DBMET01676 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |